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Summary
Background: Athletes use androgenic anabolic steroids (AAS) to enhance
their physical performance. The abuse of AAS is however associated with a
host of side effects including sudden death due to cardiac arrest. The use of
AAS leads to myocardial hypertrophy, which possibly makes the heart more
prone to ischaemia/reperfusion injury, since it often develops in the absence
of proper vasculature development.
Chronic AAS use also disrupts myocardial p-adrenoreceptor function and
possibly cAMP, signalling in the heart. Drugs increasing cAMP and
decreasing cGMP levels in the ischaemic myocardium exacerbate myocardial
ischaemia/reperfusion injury.
We also know that AAS causes coronary artery disease secondary to the
deleterious alteration of lipid profiles by increasing the LOL cholesterol and
decreasing the HOLcholesterol levels.
AAS treatment may increase systemic TNFa levels by stimulating lymphocyte
TNFa secretion that has been implicated in the depression of myocardial
function, myocardial hypertrophy and the worsening of ischaemia/reperfsuion
injury.
Aims: To determine whether chronic AAS treatment in trained and untrained
rats influences: 1) heart function and susceptibility to ischaemia/reperfusion
injury, 2) myocardial cyclic nucleotide levels (cAMP and cGMP) and 3)
myocardial TNFa levels.
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Material and methods: Male Sprague-Dawley rats (n=100) were divided into 4
groups: sedentary vehicle (placebo) treated group, sedentary AAS treated
group, exercise vehicle (placebo) treated group, and exercise AAS treated
group. Steroid treated animals received an intramuscular injection of
nandrolone laureate (0.375 mg/kg) once a week, for six weeks.
Training consisted of swim sessions 6 days a week for 6 weeks. Swim time
was incrementally increased up to a maximum of 50 minutes a day. For
biometric parameters heart weight and body weight were documented. Hearts
were mounted on a l.anqendorff perfusion apparatus and left ventricular
developed pressure (LVDP), heart rate (HR) and coronary flow (CF) was
monitored. The hearts were subjected to a period of 20 minutes of global
ischaemia, followed by 30 minutes of reperfusion. Functional parameters was
again monitored and documented. For biochemical analysis, blood was
collected for the determination of serum lipid levels and myocardial tissue
samples were collected before, during and after ischaemia for the
determination of myocardial TNFa, cGMP and cAMP levels and p38 activity.
Conclusions: Results obtained would suggest that AAS exacerbate exercise
induced myocardial hypertrophy. It also prevents the exercise-induced
improvement in cardiac function. AAS use reduces reperfusion function in
treated hearts, which may suggest that AAS exacerbates ischaemie and
reperfusion injury. Furthermore it was seen that AAS elevates basal (pre-
ischaemie) cyclic nucleotide levels and basal (pre-ischaemic) as well as
reperfusion TNFa levels. This may also contribute to the exacerbation of
ischaemic and reperfusion injury.
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Opsomming
Agtergrond: Androgeniese anaboliese steroïede (AAS) word dikwels deur
atlete gebruik om sportprestasie te verbeter. Die misbruik van AAS het egter
talle newe effekte, insluitende skielike dood wat gewoonlik toegeskryf word
aan hartaanvalle. Die gebruik van AAS lei onder andere tot miokardiale
hipertrofie wat opsigself, as gevolg van ontoereikende vaskulêre ontwikkeling
tydens die ontwikkeling van hipertrofie, die hart nog meer vatbaar vir
isgemie/herperfusie skade maak.
KronieseAAS toediening versteur miokardiale beta-adtenoresepter funksie en
moontlik die tweede boodskapper, sAMP, seintransduksie in die hart. Ons
weet ook dat AAS koronêre hartvatsiektes veroorsaak. Laasgenoemde is
sekondêr tot die nadelige lipiedprofiel verandering, wat 'n verhoging in LDL-C
en 'n verlaging in HDL-C insluit. Middels wat miokardiale sAMP vlakke
verhoog en sGMP vlakke in die isgemiese miokardium verlaag, vererger
miokardiale isgemie/herperfusie skade.
AAS behandeling kan moontlik ook sistemiese TNFa vlakke verhoog deur
limfosiet TNFa sekresie te stimuleer. Die verhoogde TNFa vlakke word
verbind aan die onderdrukking van miokardiale funksie, miokardiale hipertrofie
en die verergering van isgemie/herperfusie skade.
Doelwitte: Die doelwitte van die studie was om te bepaal of kroniese AAS
toediening in geoefende en ongeoefende rotte 1) hartfunksie en die hart se
vatbaarheid vir isgemie/herperfusie skade beïnvloed, 2) miokardiale sikliese
v
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nukleotiedvlakke (sAMP en sGMP) beïnvloed en 3) miokardiale TNFa-vlakke
beïnvloed.
Materiale en metodes: Manlike Sprague-Dawley rotte (n=100) is gebruik en in
4 groepe verdeel: 'n ongeoefende placebo groep (kontrole); 'n ongeoefende
steroïedbehandelde groep; 'n geoefende placebo groep (kontrole) en 'n
geoefende steroïedbehandelde groep. Steroïed behandelde diere het 'n
intramuskulêre nandroloon lauraat inspuiting (0.375 mg/kg) een keer per
week vir ses weke ontvang. Die oefenprogram het bestaan uit ses
swemsessies 'n week vir ses weke. Die swemtyd is geleidelik weekliks
verhoog tot by 'n maksimum tyd 50 min. Die waterbadtemperatuur is tussen
30 - 32 oe gehandhaaf. Vir biometriese parameters is hartgewig en
liggaamsgewig genoteer. Harte is op 'n Langendorff perfusie apparaat
gemonteer en linker ventrikulêre ontwikkelde druk (LVOD), koronêre vloei
(KV) en harttempo (HT) is genoteer. Die harte is vervolgens blootgestel aan
20 minute van globale isgemie gevolg deur 'n 30 minute herperfusieperiode.
LVOD, KV en HT is weer eens noteer. Vir biochemiese doeleindes is bloed
voor perfusie versamelom serum lipied vlakke te bepaal. Miokardiale weefsel
is versamel voor, tydens en na isgemie vir die bepaling van TNFa, cGMP en
AMP vlakke asook p38 aktiwiteit.
Gevolgtrekkings: Na aanleiding van resultate verkry wil dit voorkom asof die
gebruik van steroïde oefeningsgeïnduseerde miokardiale hipertrofie vererger.
Dit verhoed ook oefeningsgeïnduseerde verbetering in miokardiale funksie.
AAS lei tot 'n verlaagde herperfusiefunksie in behandelde harte, wat dalk mag
VI
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dui op MS verergering van isgemie en herperfusie skade. Verder was daar
ook waargeneem dat MS basale (pre-isgemiese) sikliese nukleotiedvlakke
en basale TNFa-vlakke sowel as herperfusie TNFa vlakke verhoog. Die
verhoging in TNF-a vlakke mag dus moontlik ook bydra tot die verergering
van isgemie- en herperfusieskade.
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% percentage
°C degrees Celsius
IJl microliter
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cm centimeter
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Panceau-S
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TRIS-HCl
Other abbreviations
AAS
ADH
ANF
ANP
ATP
cAMP
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cGMP
CHOP
DNA
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ET-1
Exerplac
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G-protein
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tris(hydroxymethyl) aminomethane hydrochloride
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atrial natriuretic peptide
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deoxyribonucleic acid
enzyme-linked immunosorbent assay
extracellular-regulated kinases
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exercise placebo (control)
exercise steroid treated
Fas-associated death domain
free fatty acids
guanine nucleotide-binding protein
Stimulatory G-protein
guanine triphosphate
high density lipoprotein
high density lipoprotein cholesterol
hepatic lipase
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IL-1
IL-6
IL-8
iNOS
Isch
JAK
JNK
Kc}+ channel
LDL
LDL-C
MAPK
MAPKAP
MEF2C
MEK
MEKK
MHC
MKKK
MLC
MRNA
NF-KB
NO
NOS
heatshock protein 25/27
hepatic triglyceride lipase
interleukin
interleukin-1
interleukin-6
interleukin-8
inducible nitric oxide synthase
ischaemia
janus-associated kinases
c-Jun NHrterminal kinase
calcium dependent potassium channel
low density lipoproteins
low density lipoprotein cholesterol
mitogen activated protein kinase
mitogen activated protein kinase associated kinase
myocyte enhancer factor-2C
MAPKlERK
MEK kinase
myosin heavy chain
MAPK kinase kinase
myosin light chain
messenger ribonucleic acid
nuclear factor-kappa B
nitric oxide
nitric oxide synthase
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PDGF
Perf
PHLPL
PKA
PKC
PKG
Repf
RNA
ROS
SAPK
Sedplac
Sedster
SERCA
STAT
TAG
TGF-j3
TNF-j3
TNF-RI
TNF-RII
TNF-a
TRADD
TRAF2
platelet derived growth factor
perfusion
post heparin lipoprotein lipase
protein kinase A
protein kinase C
cGMP dependent protein kinase
reperfusion
ribonucleic acid
reactive oxygen species
stress activated protein kinases
sedentary placebo (control)
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sarcoplasmatic reticulum Ca2+ ATPase
signal transducers and activators of transcription
triacylglycerol
transforming growth factor-beta
tumor necrosis factor beta
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TNF receptor" (TNF-R75)
tumor necrosis factor alpha
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TNF receptor associated factor 2
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Chapter 1
Introduction
It is a well-known fact that athletes use androgenic anabolic steroids (AAS) to
enhance their performance (Shahidi, 2001). The abuse of AAS has several
side effects including so-called sudden death. This phenomenon is reported in
several case studies and is generally attributed to cardiac arrest (Alen and
Hakkinen, 1985; Mewis et al., 1996; Sullivan et al., 1998).
One of the most important side effects of AAS use is the alteration of lipid
profiles. Several studies reported that the use of AAS leads to both an
increase in lOL-cholesterol and a reduction of the HOL-cholesterol (leeds et
al., 1986; Weyrich et al., 1991). These detrimental lipid profiles are known to
place subjects at an increased risk of cardiovascular diseases (Glazer, 1991).
Several cardiovascular adaptations to exercise are documented. One of the
most important relates to heart size. As mentioned earlier, endurance training
leads to an increase in heart weight, which is beneficial at first (Frenzel et al.,
1988). This may progress to a pathological hypertrophy (De Maria et al.,
1978; Steinberger, 2001). Further adaptations include an overall increase in
stroke volume (Jensen-Urstad ef al., 1998), a decrease in resting heart rate
(Wayneet al., 1998), an increased cardiac output at maximum exercise levels
(Charlton and Crawford, 1997), a lowering in resting blood pressure (lewis et
al., 1999) and an increase in blood volume (Green et al., 1991).
1
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Androgenic anabolic steroid use leads to myocardia! hypertrophy- a condition
that on its own makes the heart more vulnerable to ischaemia/reperfusion
~njury due to, amongst other things, inadequately developed vasculature
(Opie, 1995). Resistance training on its own stimulates cardiac hypertrophy
independent of AAS use (Sullivan ef aI., 1998). This is thought to be an
adaptational hypertrophy to compensate for an increase in workload
(afterioad). This compensatory hypertrophy often progresses to
decompensatory hypertrophy. This condition exists when work output per unit
of cardiac mass decreases (Meerson, 1982). It is thought that AAS
pathologically alters this beneficial physiological adaptation to exercise
(Sullivan ef aI., 1998).
There are two main signalling pathways implicated in cardiac hypertrophy: the
mitogen activated protein kinase (MAPK) pathway and the janus associated
kinase/signal transducers and activators (JAK/STAT) pathway (Ruwhof and
Van der Laarse, 2000). Other models might also explain the neqative effects
of AAS on the heart and shed some light on the possible causes for an
increased risk for heart failure. These include the thrombosis, vasospasm and
direct injury hypotheses (Melchert and Welder, 1995).
Chronic AAS administration might also disrupt myocardial beta-
adrenoreceptor and second messenger function (Norton ef aI., 2000). The
cellular mechanisms for this disruption of function have not been elucidated,
but it has been well demonstrated that myocardial ischaemia/reperfusion
injury is exacerbated by agents that increase ischaemic cAMP levels
2
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(WoUenbergeret ai, 1969; Depre and Hue, 1994) and is lessened by agents
that increase cGMP levels in the ischaemiemyocardium (Du Toit et al., 2001).
Mitogen activated protein kinases also play an important role in stress signal
transduction from the membrane to the nucleus (Cobb, 1999). Of special
interest is the p38 MAPK pathway, since it might play a protective or
deleterious role in ischaemia/reperfusion injury, and in cardiac hypertrophy.
The protective role of p38 against ischaemia/reperfusion injury involves the
phosphorylation of small heat shock proteins (hsp25/27) (Rouse et al., 1994).
Regarding the deleterious role of p38, it has been shown that the activation of
p38 generally leads to myocardial damage and apoptosis (Ma et al., 1999).
The activation of p38-MAPK and c-Jun NH2-terminal pathways has also been
implicated in alpha-1 adrenergic stimulation induced hypertrophic growth
(Wang et al., 1998).
AAS treatment has also been shown to possibly increase systemic TNF-alpha
levels by stimulating lymphocyte secretion of TNF-alpha (Hughes et al.,
1995). Tumour Necrosis Factor alpha is a pro-inflammatory cytokine
associated with ischaemia and reperfusion injury and cardiac hypertrophy.
Locally produced TNF-alpha can induce post-ischaemie dysfunction by
causing contractile dysfunction and myocyte apoptosis (Meldrum et st., 1998).
It would seem that TNF-alpha depresses cardiac function by interfering with
the calcium-induced calcium release by the sarcoplasmatic reticulum (Krown
et al., 1995). It is also possible that TNF-alpha is a mediator of myocardial
3
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cell growth when the heart is exposed to chronic low TNF-alpha
concentrations (Sack et aI., 2000).
The aim of this study was to determine whether chronic AAS treatment in
trained and untrained animals had an effect on basal heart function and if it
increased the susceptibility of the heart to ischaemic/reperfusion injury. A
further aim was to determine whether chronic AAS use influenced the
myocardial cyclic nucleotide levels, myocardial p38 activity and myocardial
TNF-alpha levels. Changes in the levels of these cytosolic proteins may
explain some of the putative negative effects of AAS on the normoxic and
ischaemie heart.
4
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Chapter2
Literature review
2.1 Androgenic Anabolic Steroids
Androgenic anabolic steroids (AAS) are almost identical to the male sex
hormones. The anabolic properties of these drugs accelerate growth by
promoting the development of muscle mass and increasing the rate of bone
maturation. In theory, the administration of AAS will increase fat free mass
and strength, which makes it an attractive supplement for athletes. It has been
postulated that anabolic steroids facilitate recovery from exhaustive training,
allowing the athletes to train harder on subsequent days. The potential for
anabolic steroid abuse among athletes is very high, and is currently a major
problem in sport. Some athletes are reported to be taking five to ten times the
recommended daily maximum dosage (Willmore and Costill, 1994). Studies
on humans and steroid abuse are relatively limited because of the stigma
attached to its use and it is therefore relied on a few reported case studies for
most of the information.
2.1.1 Casestudies of anabolic steroid abuse
Sullivan and colleagues (1998) reported that a 22-year old man was
hospitalised complaining of generalized weakness and a "funny feeling" in his
chest. The patient had been in his usual state of health until 2 weeks earlier
when he started experiencing headaches and palpitations while exercising.
His symptoms gradually worsened and became progressively associated with
generalized weakness, shortness of breath, anxiety and diaphoreses. He
denied any drug abuse (including alcohol and tobacco). He considered
5
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himself a competitive body builder, lifting weights 5 times a week for several
years. His physical examination revealed no inconsistencies. The chest
radiograph was unremarkable and his lungs clear. However, the
electrocardiogram demonstrated artrial fibrillation with rapid ventricular
response at approximately 175 beats per minute, a right axis deviation, and
inverted T-waves. He eventually confessed to using 200 mg of testosterone
cypionate, 200 mg of extrabolin decanoate and 120 mg of stanozolol two days
a week, for the previous five weeks. These are supra-physiological dosages.
An echocardiogram showed an area of significant septal hypokinesis,
posterior and septal wall thickness at the upper limit of normal, preservation of
left ventricular function, moderate left atrial hypertrophy and mild mitral and
tricuspid regurgitation.
In another case a 28-year-old man was admitted to hospital with ventricular
tachycardia (Mewis et al., 1996). Coronary angiography revealed severe
underlying coronary heart disease. The patient again had no coronary risk
factors such as a history of smoking, hypertension, diabetes, or a positive
family history for coronary heart disease. However, six months prior to his
admission to hospital, he had discontinued stanazolol use, which had
consisted of a weekly dose of 280 mg over a period of two years. Since the
risk of heart disease in the above subjects was small, it could be postulated
that AAS played a significant role in the development of their respective
cardiovascular abnormalities.
6
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An adult male body builder of international level, who decided to complement
his training by self-administering androgenic hormones at doses of 53 mg/day
volunteered as a subject in a study by Alen and Hakkinen (1985). They
investigated his physical health and fitness over a training period of 1 year.
This included only a 4-week abstinence from drug use in the middle of the
year. Results showed that the subject had atrophic testicles and low
luteinising hormone, follicle stimulating hormone and testosterone levels after
drug withdrawal. These findings indicate that sustained anabolic steroid use
leads to long-term impairment of testicular endocrine function, and
consequently leading to azoospermia and gynegomastia. The observed
decrease in serum HOL-cholesterol levels also increased the subject's risk for
atherogenesis.
2.1.2 Possibleexplanationsfor increasesin cardiovascularrisk
AAS stimulate cellular protein synthesis through androgenic receptors and
promote growth of all organs that have receptors similar to those for the
androgens (Di Bello et aI, 1999). Athletes and body builders who seek a
competitive advantage in sports require increased strength and muscle mass
and frequently abuse AAS. The use of anabolic steroids has numerous
adverse side effects that include altered endocrine function leading to
conditions such as testicular atrophy, oligospermia and decreased
testosterone levels. Hyperlipoprotenemia, hypertension, hypercachexia,
peliosis hepatis, jaundice, cholestasis and hepatonoma are some of the
additional side effects reported in athletes using anabolic steroids (Loughton
and Ruhling, 1977; Lamb, 1984; Lenders et al., 1988). Although Krieg and
7
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colleagues (1978) demonstrated a specific androgen receptor in the rat heart
muscle, the effect of chronic use of anabolic steroids on the cardiovascular
system, and in particular, the myocardium is still to a great extent unclear.
2.1.2.1 Effects of AAS on lipoproteins
Leeds and colleagues (1986) conducted experiments to investigate the effects
of anabolic steroid administration on plasma total cholesterol (TC)
concentration and plasma lipoprotein cholesterol profile in both sedentary and
anaerobically exercised male and female rats. Rats subjected to the
anaerobic exercise program demonstrated changes in their lipid profile
parallel to those observed in aerobic exercise-training studies. Male and
female rats, when grouped together, showed significant increases in HDL-C
(high-density lipoprotein cholesterol) and a significant decrease in LDL-C
(low-density lipoprotein cholesterol) concentration. When grouped together,
male and female rats treated with anabolic steroids, demonstrated a
significant atherogenic trend in their lipoprotein profiles (decreased HDL-C
and increased LDL-C). The exercise induced decrease in LDL-C in both male
and female rats was completely reversed with steroid administration. It is clear
from their study that exercise has a definite anti-atherogenic effect on the
HDL-C and LDL-C concentrations. One possible explanation for this
phenomenon involves two enzymes that playa role in lipoprotein metabolism,
namely endothelial post hepatic lipoprotein lipase (PHLPL) and hepatic lipase
(HL) (Peltonen et al., 1981; Stubbe et al., 1983). It has been suggested that
AAS increase hepatic triglyseride lipase (HTGL), which catabolises HDL
(Figure 2.1). Indeed, it was found that the use of AAS increased HL activity
8
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and decreased PHLPL. This would lead to detrimental changes in the plasma
lipid profile placing subjects at an increased risk for atherosclerosis and other
associated cardiovascular diseases (Glazer, 1991). Differences seen between
male and female rat control groups seem to follow the same trend as humans:
Males tend to have higher TC and LDL-C, and lower HDL-C than their female
counterparts and this is thought to be due to the female hormone estrogen
(Hazzard et aI., 1984). In another study Weyrich and his colleagues (1991)
examined the relationship between exogenous testosterone and blood lipids
in a non-human primate model. Results showed that the use of exogenous
testosterone not only decreased HDL-C, but also increased the plasma
concentration of thrornboxane-, The increase of plasma LDL-C by AAS could
cause fatty streaks to occur in the coronary endothelium with subsequent
endothelial injury. By both increasing platelet derived growth factor and cell
proliferation, it is possible that AAS could produce an advanced
atherosclerotic lesion (see Figure 2.1).
9
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t HTGL
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t Platelet aggregation
1
,J,. Regression of
r LOL
1
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atherosclerotic t Cell proliferation Endothelial injury
plaques
Figure 2.1: Hypothetical model of atherogenesis induced by androgenic-
anabolic steroids HTGL=hepatic triglyseride lipase; HDL=high-density
lipoprotein; PDGF=platelet derived growth factor; LDL=low-density
lipoprotein (Melchert andWelder, 1995)
2.1.2.2 Cardiac hypertrophy
Cardiac hypertrophy is a fundemental adaptation to an increased workload
due to hemodynamic overload (Cooper, 1987; Mondry and Swynghedau,
1995). The development of cardiac hypertrophy appears to be beneficial at
first, since it increases the number of contractile units and reduces left
ventricular wall stress. This adaptation is limited however, and heart failure
may follow the initial beneficial response.
10
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Several changes are associated with cardiac hypertrophy:
• The rapid induction of proto-oncogenes and heatshoek proteins
• Quantitative and qualitative changes in gene expression
• Increased rates of protein synthesis
The primary stimulus for cardiac hypertrophy appears to be mechanical stress
with an accompanying increase in neural and humoral factors (Ruwhof and
van der Laarse, 2000). Growth factors and hormones may be involved
indirectly in hemodynamic overload-induced cardiac hypertrophy. In
hemodynamic overload induced hypertrophied hearts and stretch induced
hypertrophied cardiomyocytes, the expression and release of several of these
factors have been reported and are seen as markers of cardiac hypertrophy.
These include:
• endothelin-1 (Arai et al., 1995; Yamazaki et al., 1996, Seko et al., 1999;
Serneri et al., 1999)
• Angiotensin II (Miyata et al., 1996; Tamura et al., 1998)
• Transforming growth factot-B (Villarreal and Dillmann, 1992)
• Insulin-like growth factor-1 (Serneri et al., 1999)
• Myotrophin (Sil et al., 1995)
• Vascular endothelial growth factor (Li et al., 1997; Seko et al., 1999)
• TNF-a (Klein et al., 1995)
There has been much speculation about the link between heamodynamic
overload and the induction of intracellular signals that are responsible for the
hypertrophic response. Several possible mechanisms have been implicated
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belonging to two major groups: the integrins and cytoskeleton; and the
sarcolemmal proteins (Ruwhof and Van der Laarse, 2000).
Integrins are a family of cell surface receptors that link the extracellular matrix
to the cytoskeleton at places called focal adhesion sites (Hynes, 1992; Juliano
and Haskill. 1993; Schwartz et al., 1995). Integrins may integrate a variety of
different signaling pathways that are activated by both the extracellular matrix
and growth factors to establish the coordinated hypertrophic response.
Mechanical stress can cause the deformation of the sarcolemma, which may
directly or indirectly, cause conformational changes in proteins (and their
subsequent activation) that are situated in the inner surface of cell
membranes. Several of these effector enzymes include phospholipases,
protein kinase C isoenzymes, ion channels and ion exchangers such as the
sodium/hydrogen exchanger (Ruwhof and Van der Laarse, 2000).
There are two main signal transduction pathways for cardiac hypertrophy: the
mitogen activated protein kinase pathway (MAPK), and the Janus associated
kinase/signal transducers and activators of transcription (JAK/STAT) (Ruwhof
and Van der Laarse, 2000).
Resistance training stimulates hypertrophy of the left ventricular wall and
interventricular septum independent of exogenous steroid administration
(Sullivan et al., 1998). Echocardiograms of experienced male weight lifters
showed that those actively consuming AAS had greater left ventricular mass,
increased interventricular and septal thickness compared with those either not
12
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taking steroids at all or having stopped 2 months previously (Sachtleben et al.,
1993). Supplementation with AAS therefore pathologically alters physiological
adaptations to exercise (Sullivan et al., 1998). Sachtleben and colleagues
(1993) compared 11 male weight lifters that used AAS with 13 controls 8
weeks after finishing a cycle of AAS treatment, and then again at the peak of
their next cycle. Echocardiograms showed that AAS users at peak cycle have
left ventricular septal thickness during diastole that is significantly greater than
that of either non-steroid users or steroid users 8 weeks after termination of a
cycle. In contrast to the control group, both the peak cycle and off-cycle AAS
subjects had greater left ventricular posterior wall thickness and internal
diameter during diastole.
The actual cellular mechanism by which AAS promotes myocardial
hypertrophy is still inconclusive. In a recent study, Woodiwiss and colleagues
(2000) investigated the effects of androgenic anabolic steroids on exercise-
induced cardiac remodeling in rats. Habitual exercise results in a rightward
shift in the left ventricular end diastolic pressure volume relationship.
However, exercise mediated left ventricular hypertrophy produces an increase
in left ventricular wall thickness despite left ventricular remodeling. They found
that high dose androgenic steroid administration alters exercise induced left
ventricular remodeling and subsequently reduced the beneficial effect of
physiological left ventricular hypertrophy on left ventricular wall thickness to
internal radius. Tagarakis and colleagues (2000) compared sedentary female
mice (with or without anabolic steroid administration) to treadmill exercised
female mice (with or without anabolic steroid administration). They found that
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anabolic steroids combined with exercise, induced mild hypertrophy of the
cardiac myocytes, and impaired the cardiac microvascular adaptation to
physical conditioning. This impairment might cause a detrimental alteration in
the myocardial oxygen supply, especially during muscular exercise. This may
also make the heart more prone to ischaemic injury as one would expect with
compromised myocardial perfusion. McAinsh and colleagues (1995)
investigated whether impaired coronary flow reserve associated with cardiac
hypertrophy could exacerbate prolonged episodes of ischaemia. They found
that the hypertrophied heart was more vulnerable to brief periods of ischaemia
because of an impaired reactive hyperaemic response, which results in a
delayed metabolic recovery.
2.1.2.3 Thrombosis, vasospasm and direct injury
There are several other detrimental consequences associated with the use of
AAS that may negatively affect the heart. The absence of classical risk factors
for heart disease, the youth of patients taking anabolic steroids and the lack of
arterosclerotic lesions, raised several questions on the prothrombotic effects
of high dose androgens (Ferenchick, 1991). It has been suggested that an
increase in platelet aggregability with adenosine diphosphate and collagen
can be significantly increased in abusers of anabolic steroids compared to
their fellow male weight lifters that do not use anabolic steroids. It would seem
that high dosages of anabolic steroids are capable of increasing vascular tone
and reactivity, i.e. blood pressure and platelet aggregability (Ferenchick et al.,
1992).
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induced exacerbation of cardiovascular injury. The first model is called the
Several possible models have been suggested as possibilities for the AAS
thrombosis model where AAS are thought to facilitate thrombosis by altering
vascular reactivity, enhancing platelet aggregation, and increasing the
concentration and activity of particular procoagulant factor proteins
(Ferenchick ; 1991 and Ferenchick et al., 1992).
AAS
t Factor IX t Factor VII
~~
t platelet aggregation
l
t Factor Xa
t Thrombin activity r Blood clotting
Figure 2.2: Hypothetical model of thrombosis induced by androgenic
anabolic steroids (AAS). Factor X and VII probably play a lesser role.
(Melchert et al., 1995)
The second model is called the coronary artery vasospasm model, which is a
hypothetical explanation for AAS induced myocardial infarction in the absence
of both artherosclerosis and thrombosis. Nitric oxide acts as an endothelial
derived relaxing factor in coronary arteries by acting on guanylyl cyclase to
increase cyclic guanosine monophosphate (cGMP) which in turn leads to
vascular smooth muscle relaxation (Peach et al., 1985; Ignaro, 1989). Chronic
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relaxationpossiblyby inhibitingguanylylcyclase(Ferreret a/., 1994).
administrationof nandroloneto rabbits resulted in decreasedthoracic aorta
AAS
t OxidizedLOL
(\
Endothelialcell___.NO
VascularSmoothMuscleRelaxation
Figure 2.3: Hypothetical model of inhibited vascular smooth muscle
relaxation, or potential vasospasm induced by androgenic anabolic
steroids (AAS). LOL = low density lipoproteins; GTP = guanosine
triphosphate; cGMP= cyclic guanosine monophosphate; NO = nitric
oxide; (+) = stimulatory; (-) = inhibitory (Melchertet a/., 1995)
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The third model is the direct injury model where anabolic steroids directly
injure myocardial cells.
AAS
l
Myocarlal cell injury
Fibrosis
l
venlricur arrhythmias
Sudden Cardiac Death
Figure 2.4: Hypothetical model of direct myocardial injury induced by
androgenic anabolic steroids (AAS) (Melchert et al., 1995)
Behrendt and colleagues (1977) have found that after exposure to
methandrosstenolone, the mitochondria within the rat left ventricle enlarge,
become rounded with membrane defects and an electron lucent matrix, and
then elongate, leaving a sparse matrix material and few cristae. Melchert and
colleagues (1992) also demonstrated the potential cardiac toxicity of anabolic
steroids. They exposed primary myocardial cell cultures to testosterone
cypionate, stanozolol and fluxymesterone. Myocardial cellular destruction was
associated with depressed contractile activity, increased lysosomal fragility,
and depressed mitochondrial activity in myocardial cells.
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2.1.3 Estrogensversusandrogenicanabolicsteroids
Woman seems to be protected against heart disease, and only after the drop
in estrogen levels during and after menopause, do they experience an
increase in risk for coronary artery disease (Henderson et al., 1988 and
Stampfer et aI., 1991). It has long been postulated that estrogen gives
females a cardioprotective advantage. One of the main hypotheses for this
cardioprotective effect is that there is a link between NO production and
estrogens (Rosselli et al., 1994). It has been suggested and experimentally
proven that estrogens stimulate the formation of NO in endothelial cells, which
in turn stimulates the production of cGMP in the coronary artery and smooth
muscle cells. These events will then lead to a lowering of intracellular calcium,
which leads to vasodilation (Wellman et al., 1996). A study investigating 17J3-
estradiol and cardiac leukocyte accumulation in myocardial ischaemia and
reperfusion injury in rats was conducted by Squadrito and colleagues (1997).
They found that 17J3-estradiolsignificantly lowered TNF-a production. This
cytokine is an important role player in ischaemia and reperfusion injury. In
another study, Van Eickles and colleagues (2001) showed that 17p-estradiol
attenuated the hypertrophic response to pressure overload in mice. In a study
conducted by Webb and colleagues (1998), they found that estrogen also
improved exercise-induced myocardial ischaemia in woman.
Thus, in contrast to the beneficial effects of estrogen, it would seem that
androgenic anabolic steroid hormones are harmful to the cardiovascular
system, while estrogens playa beneficial role.
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2.2 Myocardialischaemiaand reperfusioninjury
The exact definition of ischaemia in the heart is still under debate, but it
essentially refers to a condition of inadequate blood supply to the
myocardium. This happens when coronary blood flow restriction to the
myocardium is so severe that the oxygen demand of the tissue outweighs the
oxygen supply in the tissue (Opie, 1995). By definition, ischaemia exists
"whenever the flow of arterial blood through the diseased vessels is reduced
to a volume below that required by the myocardium for adequate function"
(Jennings, 1970). Acute ischaemia induces a wide variety of derangements,
from reversible myocardial stunning to irreversible abnormalities such as
myocardial infarction. These abnormalities are usually accentuated upon
reperfusion of the myocardium (Boyle et al., 1997).
By reintroducing blood flow, the myocardial tissue can be rescued. However,
reperfusion of the myocardial tissue not only reoxygenates the tissue, but also
triggers a range of complicated cascades and reactions that can also lead to
the dysfunction of the myocardium (Vermieren et al., 2000). Two mechanisms
of defense against ischaemia in the myocardium have been proposed: 1) a
short-term acute adaptation defense and 2) a long term rescue (Hochcachka
et al., 1996).
There is an almost immediate energy imbalance with the onset of ischaemia.
The lack of blood flow and hence, the lack of oxygen delivery to the
myocardium reduces oxidative phosphorylation leading to failure in the
resynthesis of high energy phosphates (Maxwell and Lip; 1997), especially
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phosphocreatine which acts as a reservoir for adenosine triphosphate (ATP)
levels in the myocardium. This depletion is one of the dominant signals for a
decrease in heart contractility and the onset of increased anaerobic glycolysis.
There are two main hypotheses for ischaemic contractile dysfunction. The first
involves the depletion of the high-energy phosphates, with special emphasis
on creatine phosphate. The second hypothesis is based on the accumulation
of metabolic products that causes pump failure (Dennis et a/., 1991). A
controversial explanation for the reduction in myocardial contractility during
ischaemia is a reduction in ~-adrenergic signal transduction caused by
reduced ~-adrenergic receptor density and adenylate cyclase activity (Dupuis
et aI., 1997). Following reperfusion, the depressed contractility is less severe
and is accompanied by an increase in ~-adrenergic signal transduction,
indicated by an increase in cAMP. This appears to be the result of increased
~-adrenergic receptor density and adenylate cyclase activity (Dupuis et a/.,
1997).
Cellular leakage of ions plays a key role in myocardial disruption during
ischaemia. Once tissue is subjected to an ischaemic environment, the
electron transport system becomes impaired, leading to a reduction in
available energy to the tissue. Several cellular and subcellular ATP-
dependent mechanisms become inactive, leading to a general leakage of
cellular ions and substrates into the extracellular environment (Sobel and
Shell, 1972; Vatner et a/., 1978). The cell can then no longer maintain or
restore its homeostatic equilibrium and will fail (Sobel and Shell, 1972). Ion
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homeostasis is lost with a leakage of potassium ions into the extracellular
environment and calcium ions into the cytoplasm (Maxwell and Lip, 1997).
2.2.1 Effectsof ischaemia/reperfusionon pH
The combination of carbon dioxide and proton accumulation decreases the
pH of the myocardial tissue (Cross et al., 1995). This cellular acidosis can be
argued as either beneficial or detrimental to the ischaemiemyocardium. A low
pH inhibits the enzyme 5'-nucleotidase, which breaks down adenosine
monophosphate. The inhibition of this breakdown ensures a more rapid ATP
synthesis during the reperfusion period following ischaemia (Back and
Ingwall, 1994). On the other hand it is possible that a very low pH might
activate Iysosomes, which may lead to the irreversible destruction of the
ischaemic myocardial tissue (Bing et al., 1973).
2.2.2 Effectsof ischaemiareperfusionon cytosolic Ca2+
Another very important consequence of ischaemia is the disruption of the
calcium homeostasis, which leads to several detrimental changes in the
myocardium.
In the normal myocardium there is a close relationship between oxygen
consumption and contractile performance in the heart and although
myocardial oxygen consumption recovers to baseline rapidly after reperfusion,
there is a continued depression of regional systolic shortening (Huang and
Liedtke, 1989). Cytosolic calcium is increased during prolonged ischaemia
(Marban et aI., 1998a). This consistent increase in calcium happens, either
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before, or concurrently with the onset of ischaemic contracture, or just after
the maximal depletion of ATP. The increased calcium has several diverse
consequences including damage to contractile proteins, activation of
phospholipases, increased depolarization, ischaemic contracture and
mitochondrial damage (Myers et al., 1995).
As mentioned before, reperfusion of ischaemic tissue initiates a cascade of
processes. In order to limit the so-called reperfusion injury, it is essential to
understand the underlying mechanisms and triggers of this reperfusion
phenomenon (Vermieren et al., 2000). Reperfusion injury is a syndrome of
related conditions that follows reperfusion of the ischaemic myocardium. The
mechanisms for reperfusion injury is two-fold, one being cytosolic calcium
overload and the other being the formation of free radicals. Other events
linked to myocardial reperfusion injury include endothelial dysfunction,
reintroduction of neutrophils into the ischaemic area (Forde and Fritzgerald
1997) and microvascular damage (Opie, 1998).
The increase in cytosolic calcium during ischaemia is often exacerbated
during reperfusion (Nayler et al., 1980).The source of calcium can be external
or internal. The uptake of calcium during the early stages of reperfusion can
result from sodium-calcium exchange activation (Du Toit and Opie, 1993) or
from calcium entry via the L-type Ca2+ channels (Du Toit and Opie, 1992).
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2.2.3 Free radicals and ischaemia/reperfusion
Free radicals are highly reactive chemical species. They differ from standard
compounds by having unpaired electrons in their outer orbital. Oxygen-
derived free radicals include the superoxide radical or superoxide anion. The
danger exists that the superoxide anion can react with hydrogen peroxide to
form a more reactive hydroxyl ion (Opie, 1995). A potential source of reactive
oxygen-derived free radicals in ischaemic and reperfused tissues is the
enzyme xanthine dehydrogenase/oxidase (Maxwell and Lip, 1997).
Peroxidation of membrane lipids in the myocardium can be caused by free
radical formation and can contribute to reperfusion injury (Meerson et al.,
1982). The free radical and calcium hypotheses can be integrated. Free
radicals may promote calcium overload by:
• Interfering with myocardial calcium transport, either at sarcoplasmic
reticulum or cell membrane level
• Impairing mitochondrial oxidative phosphorylation and directly inhibiting
glyceraldehyde-3-phosphate dehydrogenase
• Irreversible inhibition of anaerobic glycolysis
Calcium overload may in turn promote the production of free radicals by
damaging the electron transport chain, which may lead to the leakage of free
radicals. This can activate calcium dependant proteases leading in turn to the
activation of xanthine oxidase (Maxwell and Lip, 1997).
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2.2.4 Endothelialdysfunctionandreperfusioninjury
Endothelial dysfunction may play an important role in reperfusion damage.
Superoxide anions can, in fact be generated in endothelial cells during
reoxygenation. It also seems that endothelial cells are targets for free radicals
(Leferetal., 1991; Mcfalls etaI., 1991; Sobey etaI., 1992). Endothelin-1 (ET-
1) is a potent vasoconstrictor peptide that is derived from the vascular
endothelial cells. Other sources include smooth muscle cells and
cardiomyocytes themselves. During ischaemia and myocardial reperfusion,
the production and release of ET-1 is stimulated and the coronary constrictor
response towards this substance is enhanced. Experimental evidence
suggests that ET-1 plays an important role in the pathophysiological state of
the reperfused myocardium, enhancing the ischaemia-reperfusion injury of the
heart (Pernow and Wang, 1997; Brunner et al., 1992).
An inflammatory response has been observed with reperfusion by activation
of a wide variety of cells, including monocytes, macrophages, endothelial cells
and T-cells. These cells lead to the activation of cytokines such as tumor
necroses factor (TNF) and interleukins (IL). IL-8 is known to be a neutrophil
activating substance (Opie, 1998). Neutrophil activation can be divided into
several stages. First, the neutrophils accumulate in the vasculature of the
ischaemic area, mainly facilitated by the secretion of chemotactic factors,
such as leukotrines and other cytokines. Once the neutrophils are established
in the vasculature, the neutrophil acts directly with endothelium to enter the
tissue. During the next phase, the neutrophils penetrate the interstitium of the
tissue and release the contents of their granules (Verrnieren et al., 2000).
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Once inside the vascular interstitial space, the neutrophils are activated and
thought to liberate free radicals and leukotrines (Opie, 1998)
2.3 Exerciseand the cardiovascularsystem
Exercise is associated with extensive alterations in the circulatory and
respiratory systems as part of the homeostatic responses that make moderate
to severe exercise possible (Ganong, 1995). The skeletal system provides the
basic framework through which muscles act, the cardiovascular system
delivers nutrients to the body's various cells and in return removes waste
products. The cardiovascular and respiratory systems work together to
provide oxygen to cells and remove carbon dioxide. The integumentary
system helps to maintain body temperature by allowing the exchange of heat
between the body and its surroundings. The urinary system maintains fluid
and electrolyte balance and provides long-term blood pressure regulation.
The nervous system and endocrine systems in turn coordinate and direct all
these activities to meet the needs of the body (Willmore and Costill, 1994).
The heart itself goes through structural changes during prolonged exercise.
The myocardium undergoes hypertrophy, and to a lesser degree hyperplasia.
Hypertrophy refers to cells becoming larger, whereas hyperplasia refers to the
increase in cell numbers. The latter happens to a lesser extent in response to
exercise. With extensive exercise hypertrophy is beneficial, because of the
increase in contractile units. This type of hypertrophy can progress to a state
of pathophysiological hypertrophy. In the hypertrophied myocardium there is
an increase in myocyte size. Capillaries and interstitial cells, containing
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collagen, increase via hyperplasia, although this happens to a lesser extent.
The capillary surface area remains the same though, leading to a decrease in
the surface area to total volume area. When the cell volume increases by
approximately 60%, beta-receptor density decreases by about 33%. The
sodium-calcium exchange rate decreases as well as the density of the
calcium-ATPase pump in the sarcoplasmic reticulum. There is however, a
relative increase in the T-tubules and the surface area of the sarcoplasmic
reticulum. This is a possible compensatory mechanism in response to the
decreased density of the sarcolemmal calcium pump. All these changes could
contribute to the abnormalities of contraction observed in the hypertrophied
pathologically heart (Opie, 1998).
The myocardium also undergoes an accumulation in collagen, termed fibrosis.
Initially there is an increase in interstitial collagen dubbed reactive fibrosis.
This leads to a general increase in stiffness of the myocardium both in systole
and diastole. Stiffness during systole might improve force generation (Weber
ef ai., 1989) while, during diastole, it might lead to impaired relaxation rates
(Brilla ef aI., 1991).
2.3.1 The blood supply and oxygen utilization of the heart
There are no direct circulatory channels within the hearts' chambers, so the
heart relies on coronary circulation for its oxygen and nutritional needs. Even
at rest, oxygen utilization of the myocardium is high in relation to the blood
flowing through the coronary vessels. The increase in myocardial oxygen
demand during exercise can only be met by a proportional increase in
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coronary blood flow. It has been noted that during vigorous exercise, coronary
blood flow can increase up to four to five times that of the normal resting level.
This increase is achieved in two ways:
1)An increase in myocardial metabolism has a direct effect on the coronary
vessels, causing them to dilate via local factors and hormones of the
sympathetic nervous system.
2) Exercise results in an increase in aortic pressure, which forces a
proportionately greater quantity of blood into the coronary circulation.
Adequate oxygen supply is critical for the myocardium, because its tissue has
a limited ability to generate energy anaerobically (Tune et aI., 2002)
2.3.2 Cardiovascularadaptations to exercise
Numerous cardiovascular adaptations occur in response to training, which will
be discussed below.
2.3.2.1 Heartsize
Endurance training leads to an increase in heart weight, specifically an
increase in left ventricle wall thickness and chamber size. This is a biological
adaptation to an increased workload. (Frenzel et aI., 1988). Earlier
researchers called this adaptation "athletes heart", because experts believed
that the enlargement of the heart to be a pathological state. Currently it is
recognized as a normal result of chronic exercise training. Endurance training
leads to an increase in chamber size as well as an increase in myocardial
thickness previously believed only to occur with resistance training. This
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results in a stronger heart that can generate a relatively larger stroke volume
(Oakley, 2001).
It is important to distinguish between physiological hypertrophy versus
pathological hypertrophy. Left ventricular hypertrophy can be classified as 1)
physiological hypertrophy or 2) pathological hypertrophy. The first is induced
due to long term exercise (De Maria et al., 1978)while the latter is induced by
abnormalities such as volume overload, insulin resistance (Steinberger,
2001), obesity (Lauer et al., 1991), aortic stenosis, or anabolic steroid abuse
(Ferrer et al., 1994; Melchert and Welder, 1995). Exercise induced LV
hypertrophy is associated with normal or improved cardiac function while
pathological LV hypertrophy is associated with impaired systolic contraction,
diastolic relaxation and an increase in diastolic stiffness (Lecarpentier et al.,
1987, Doering et al., 1988;). Evidence would also suggest that elevated
myocardial cytokine levels (TNF-a, IL and Cardiotrophin-1) might cause
decompensation, dilatation, and heart failure in the hypertrophied heart
(Kubota et al., 2000; Latchman, 2000).
2.3.2.2 Stroke volume
There is an overall increase in stroke volume in response to endurance
training. A stronger heart and the availability of a larger blood volume appear
to account for the increase in rest, submaximal, and maximal stroke volumes
following an endurance exercise program (Eshani et al., 1991). Training
increases blood plasma volume, which leads to a greater end diastolic
volume. The larger volume of blood entering the ventricle leads to stretching
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of the walls, which may result in more elastic recoil (Frank-Starling law). At the
same time, there is hypertrophy of the posterior and septal walls of the left
ventricle, leading to stronger contractility. This means that more blood enters
the left ventricle, and a larger percentage of this blood is ejected with each
contraction (Ginszton et al., 1989; Jensen-Urstad et al., 1998).
2.3.2.3 Heart rate
Heart rate and oxygen consumption are linearly related for both trained and
untrained individuals. Resting heart rate decreases considerably as the result
of endurance training. Highly trained athletes often have a resting heart rate of
only 40 beats/minute or even less 0Nayne et al., 1998). Heart rate during
submaximal exercise also decreases proportionately with the training
completed. Maximal heart rate either remains unchanged or decreases
slightly with training. This slight decrease in maximal heart rate is probably to
allow for a proper stroke volume to maximize the cardiac output (Jones and
Carter; 2000).
2.3.2.4 Cardiac output
Cardiac output, at rest or during sub maximal exercise, remains unchanged or
decrease slightly, but cardiac output at maximal levels of exercise, increases
considerably. This is mainly because of the substantial increase in the
maximal stroke volume in the trained individual (Charlton and Crawford;
1997).
29
Stellenbosch University http://scholar.sun.ac.za
2.3.2.5 Blood flow
Training leads to an enhanced blood supply to skeletal muscles (Kalliokoski et
al.,2001).
Three factors account for this:
i) Increased capillarization of trained muscles
ii) Larger opening of existing capillaries in trained muscles
iii) More effective blood distribution
These factors lead to an increase in the cross sectional area of the vascular
bed as well as a decrease in the distance between blood and active cells for
the diffusion of oxygen and metabolites (Brevetti et aI., 2001).
2.3.2.6 Blood pressure
Resting blood pressure is usually reduced by endurance training in people
with borderline to moderate hypertension. Endurance training has, however,
little or no effect on blood pressure during standardized submaximal or
maximal exercise (Lewis et aI., 1999).
2.3.2.7 Blood volume
Endurance training increases blood volume. This increase in blood volume is
the result of an exercise-induced increase in the blood plasma volume. Blood
plasma volume is increased by two mechanisms:
1) Exercise increases the release of antidiuretic hormone (ADH) and
aldosterone. These two hormones act on the kidneys to promote water
retention, thus resulting in an increase in blood plasma volumes (Willmore
and Costill; 1994).
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2) Exercise increases the amount of plasma proteins and in particular
albumin in the blood. With the increase in plasma protein concentration,
there is an increase in the osmotic pressure leading to the retention of
more fluid in the vascular compartment (Green ef al., 1991).
2.4 Cyclic nucleotides in the normal, ischaemie, and
hypertrophiedheart
Accumulating evidence suggests that ventricular pathophysiological
hypertrophy is associated with contractile dysfunction, impaired tolerance to
ischaemia and increased risk during cardiac surgery. Allard and colleagues
(1994) compared calcium overload and morphologically evident myocardial
injury in hypertrophied hearts and normal hearts subjected to ischaemia. They
found that calcium overload was two and a half times greater in hypertrophied
hearts than in their normal counterparts. During myocardial ischaemia these
hearts also exhibited an accelerated loss of high-energy phosphates, larger
accumulation of tissue lactate and an earlier onset of ischaemic contracture.
Studies have also reported increased dependence on glycolysis for energy
metabolism and changes in intracellular calcium regulation and excitation-
contraction coupling (Chang ef al., 1996).
In eukariotes the cyclic nucleotides 3', 5' cyclic adenosine monophosphate
(cAMP) and 3', 5'- cyclic guanosine monophosphate (cGMP) help transmit
information from extracellular hormones to intracellular enzymes. (Horton
et.al., 1996). Many hormones that regulate intracellular metabolism exert their
effects on target cells by activating the adenylate cyclase pathway. Binding of
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a hormone to a stimulatory receptor causes the conformational change of the
receptor, which promotes the interaction between the receptor and a G
protein named protein Gs that in turn binds to an effector enzyme named
adenylate cyclase and activates it (Horton et al., 1996).
2.4.1 cAMP
Adenylate cyclase is an integral membrane enzyme with an active site facing
the cytosol. It catalyses the formation of the second messenger, cAMP, from
ATP. Cyclic AMP diffuses from the membrane surface into the cytosol and
activates the enzyme protein kinase A, a serine, threonine protein kinase.
Protein kinase A catalyses the phosphorylation of the hydroxyl groups of
specific serine and threonine residues on target enzymes. Phosphorylation of
the amino acid side chains is reversed by the action of protein phosphatases
(Ganong, 1995).
Hormones that bind to stimulatory receptors activate adenylate cyclase and
raise cAMP levels. Hormones that bind to inhibitory receptors inhibit adenylate
cyclase activity. The ultimate response of a cell to a hormone depends on the
type of receptor present in the cell and the type of G protein to which they are
coupled (Ganong, 1995).
There is strong evidence linking myocardial ischaemic and reperfusion injury
to calcium overload (Marban ef al., 1989b). The cardiac L-type Ca++ channel
is an important determinant of myocardial contractility. Its regulation via neural
and hormonal factors contributes to the control of cardiac output. A large
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number of these extracellular first messengers act on specific membrane
receptors in cardiomyocytes and regulates the activity of adenylate cyclase.
Adenylate cyclase in turn controls the intracellular levels of cAMP, the activity
of the cAMP dependent protein kinase, and the degree of phosphorylation
and stimulation of L-type Ca++ channels (McDonald ef a/., 1994; Hove-
Madsen ef a/., 1996; Striessnig, 1999). Increased cAMP levels associated
with ischaemia (Wollenberger ef a/., 1969; Depré and Hue, 1994) would
therefor increase Ca++levels and exacerbate reperfusion injury.
Osaki and colleagues (1997) found that in perfused adult rat hearts, c-fos
expression is induced by acute aortic pressure overload and is coupled to
increases in cAMP content. The pressure-induced induction of c-fos may play
a transducing role in the cAMP-dependant protein synthesis system by which
stretch of the left ventricular wall, consequent to acute aortic pressure,
increases rates of protein synthesis. There is therefore evidence linking
abnormal cAMP levels to both myocardial hypertrophy and
ischaemia/reperfusion injury.
2.4.2 cGMP
Cyclic GMP is a second messenger that regulates physiological processes in
various cell types, such as retinal rods, renal tubular cells, platelets and
muscle cells (Schmidt ef a/., 1993). In the heart, cGMP may increase or
decrease cAMP by its effect on cAMP phosphodiesterases, and stimulate
PKG, which inhibit inward Ca++currents (Lohman ef a/., 1991). The cardiac L-
type Ca2+is especially important in this regard, since the channel current is an
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important determinant of myocardial contractility. Its regulation by
neurotransmitters, hormones, and paracrine factors contributes to the control
of cardiac output (Hartzell, 1988; McDonald et al., 1994).
Guanylyl cyclases are a family of enzymes that catalyses the formation of
cGMP. There are two types: the particulate form which is stimulated by ANP,
and the soluble form which is stimulated by NO (Walter, 1989). These
isoforms are of special interest since it would seem that NO is involved in the
modulation of cardiac contractility and rhythm, in part through its ability to
control the amplitude if the L-type Ca++current (Shah and MacCarthy, 2000).
This regulation is mediated through the generation of cGMP by NO-stimulated
soluble guanylyl cyclase (Chesnais et al., 1999). Besides its effects on
myocardial contractility, the NO-cGMP pathway stimulation during ischaemia
may protect the heart against ischaemia/reperfusion induced calcium overload
(Du Toit et al., 2001). It is believed that elevated cAMP levels in the heart
would exacerbate ischaemia/repefusion injury by elevating the cytosolic
calcium levels (Du Toit and Opie, 1992). In this regard it is possible that
cGMP may attenuate this type of injury by inhibiting the cAMP induced slow
inward calcium current thus leading to a decrease in cytosolic calcium levels
(Hartzell and Fischmeister, 1986; Summi and Sperelakis, 1995). Another
protective pathway might be the NO-cGMP dependent pathway in which the
sarcolemmal I<ATP channels are opened and the cystolic calcium levels are
lowered (Figure 2.5).
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Figure 2.5: A proposed model to explain the role of NO in reducing
myogenictone in coronaryarteries (Adapted fromWellman et al., 1996)
2.5 Mitogen-activatedprotein kinases
Mitogen activated protein kinases (MAPK) are present in all eukaryotes and
play an important role in signal transduction from the membrane to the
nucleus (Herskowitz 1995; Lewis et al., 1998; Cobb, 1999). During a cell's
lifetime, it needs to respond to various stress stimuli, to which the cell will
either adapt or undergo cell death. These stresses include inflammatory
cytokines, ischeamia, ATP depletion, endotoxin and genotoxic stress
(Nagarkatti and Sha'afi, 1998). Cells respond to these extracellular signals by
transmitting intracellular instructions to coordinate the correct responses.
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The mitogen activated protein kinase pathway and the extracellular signal
regulated protein kinase (ERK) cascades are often used to transduce these
signals. Three pathways lead to the activation of three different sets of MAP
kinases. Two of these pathways can participate in overlapping stress
responses and are referred to as stress pathways. Activation of these
pathways lead to growth arrest and apoptosis. The other pathway stimulates
proliferation and differentiation and is subsequently named the mitogenic
pathway (Tibbles andWoodgett, 1999).
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Figure 2.6: The cytoplasmic-signalling cascade (Adapted from Sudgen
and Clerk, 1998)
The three best-characterized MAPK pathways are the extracellular regulated
protein kinases (ERKs), the c-jun NHz-terminal kinases (JNKs) and the p38
MAPK cascade (Robinson and Cobb, 1997).
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All MAPKs phosphorylate Serine/threonine residues in proteins within a
(serine/threonine) Pro consensus motif, but additional factors dictate the
precise substrate specificity (Yao et a/., 1995).
The MAPK cascade consist of a three kinase module that includes a MAPK,
which is activated by a MAPKlERK kinase (MEK), which in turn is activated by
a MEK kinase (MEKK) (Schlessinger, 1994; Blenis, 1993). The MEKs are
substrates for Raf-1 which can be activated through either receptors involved
in Ras or a protein kinase C (PKC)-dependent pathway. These MAPK
activators cause translocation from the cytosol to the nucleus, where
transcription factors such as c-Jun, Elk-1 and c-Myc are substrates for MAP
kinase (Pulverer et al., 1991; Seth et a/., 1991; Janknecht et a/., 1993). In
response to stress via the small GTP binding protein MAPK kinase, MEKK1
and dual specificity protein kinases MKK3, MKK4 and MKK6 are activated
(Force et al., 1996).
At least four isoforms of p38 have been identified:
• P38a
• P38~
• P38y
• P38ó
P38 a and p38 ~ can both be blocked with the blocker SB203580. P38 has
cellular functions that are not only related to stress responses, but also
unrelated to stress responses as illustrated in Figure 2.7 (Nebreda and
Porras, 2000).
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Figure 2.7 summarises the very diverse actions of p38 in various systems.
This ranges from proliferation and differentiation to stress, inflammation and
apoptosis.
Inflammation Stress Apoptosis
Drosophila Survival CardiomyocytesFibroblasts
Neuronsdevelopment
Differentiation Proliferation
Adipocytes
Cardiomyocytes
Chodroblasts
Erythroblasts
Myoblasts
Neurons
Fibroblasts
Haematopoietic
cells
Figure 2.7 Cellular functions of p38 that are related and unrelated to
stress (Nebreda and Porras; 2000)
2.5.1 P38 and ischaemia
2.5.1.1 Protective role of p38
On the one hand, p38 kinase can activate mitogen-activated protein kinase-2,
which phosphorylates small heat shock proteins (hsp25/27) (Rouse et al.,
1994). These small proteins act as an F actin cap binding protein and
modulate actin filament dynamics. Activation of the heat shock proteins leads
to the protection of cells to ischaemie injury (Martin et al., 1997). When p38
was blocked, the cardioprotective effect was abolished (Maulik et al., 1998;
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Armstrong et al., 1999 and Nakano et al., 2000). This apparent protection
against ischaemie injury is referred to as ischaemie preconditioning, where
brief episodes of ischaemia or pharmacological agents protect the
myocardium against subsequent ischaemie damage (Downey and Cohen,
1997).
2.5.1.2 Deleterious role of p3S
On the other hand, several studies have reported that the blocking of p38 with
SB203580 and SB202190 lead to improved post-ischaemie functional
recovery (Saurin et aJ., 1999; Schneider et al., 1999; Barancik et al., 2000).
The activation of p38 generally leads to myocardial damage and myocyte
apoptosis. Ma and colleagues (1999) have indeed shown that the inhibition of
p38 MAPK decreased cardiomyocyte apoptosis and that the inhibition also led
to improved cardiac function after myocardial ischeamia and reperfusion.
Nagarkatti and Sha'afi (1998) also found that the activation of p38 MAPK was
decreased in preconditioned cells, further implicating p38 MAPK in a
deleterious role in the heart. In response to oxidative stress, cardiac injury
might also be mediated by a p38 MAPK-mediated production of TNFa
(Meldrum et a/1998).
2.5.2 P3S and hypertrophy
The activation of p38-MAPK and c-Jun NH2-terminal kinase (JNK) has also
been implicated in alpha-1 adrenergic stimulation induced hypertrophic growth
(Wang et al., 1998). It is possible that the p38 MAPK pathway is involved in
mechanical stress-induced hypertrophy. Evidence supporting this hypothesis
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was found in a mouse model of pressure overload where p38 activity was
increased (Wang et al., 1998). As mentioned before, markers of cardiac
hypertrophy include the so-called early response genes (e.g. erg-1, hsp-70, e-
fos, e-jun and e-mye) (Hefti et al., 1997). MEKK3 and MEKK6 both activate
p38-MAPKs preferentially. Transfection of neonatal cardiac myocytes with
these two constitutively activated upstream activators stimulate the
expression of ANF and skeletal muscle a-actin and is associated with the
hypertrophic response (Sudgen and Clerk, 1998).
The seemingly contradictory activation of p38, which leads to cell proliferation
and growth versus apoptosis, might be due to the different isoforms of p38. It
would seem that p38p activation leads to hypertrophy while the activation of
p38a leads to the induction of myocyte apoptosis (Wang et al., 1998).
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Figure 2.8: Proposed role of p38 in cardiac hypertrophy and heart failure
in response to haemodynamic stress (Wang et al., 1998)
P38 can also phosphorylate C/EBP homology protein (CHOP), also known as
growth arrest and DNA damage-153 (Wang and Ron; 1996). Expression of
MKK6 enhanced the ability of etopically expressed MyoD, an essential
transcription activator in myogenesis, to differentiate 10T1/2 fibroblasts to
muscle cells. The stimulation of muscle gene expression by p38 is apparently
mediated by the myocyte enhancer factor-2C (MEF2C) transcription factor.
This suggests the p38 might regulate MyoD activity via phosphorylation and
increases the transcriptional activity of MEF2C (Galbiati et al., 1999).Whether
the cell is committed to death or survival will depend on the stimulus and
cellular context (Nagarkatti and Sha'afi, 1998).
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2.6 Tumor Necrosis Factor alpha
Tumor Necrosis Factor (TNF) is a pro-inflammatory cytokine, existing in both
the alpha (a) and beta (13) form, but TNF-a is the cytokine associated with
ischaemia and reperfusion injury. TNF-a is implicated in several
cardiovascular diseases and abnormalities. These include acute myocardial
infarction, chronic heart failure, atherosclerosis, viral myocarditis, cardiac
allograft rejection and sepsis-associated cardiac dysfunction (Levine et ai.,
1990; Yokoyama et ai., 1992; Latini, 1994; Neumann et ai., 1995; Torre-
Amione et al., 1995; Biasucci et ai., 1996; Torre-Amione et ai., 1996a; Torre-
Amione et aI., 1996b; Oral et ai., 1997; Yokoyama et ai., 1997). It has been
established that resident cardiac macrophages can produce TNF-a (Neumann
et aI., 1995; Kapadia et ai., 1995; Kapadia et ai., 1995; Biasucci et ai., 1996;
Kumar et ai., 1996;) but surprisingly cardiac myocytes themselves are a major
source of TNF-a (Kapadia et aI., 1995). It has also been shown that
endotoxin-induced TNF-a production is evenly distributed between the
resident cardiac macrophages and cardiac myocytes (Kapadia et ai., 1997).
Several scenarios stimulate TNF-a production, including ischaemia and
reperfusion (Herskowitz et al., 1995; Gurevitch et aI., 1996), burn trauma
(Horton, 1996), clinical myocardial infarction (Latini et ai., 1994, Neumann et
ai., 1995; Biasucci et ai., 1996), cardiopulmonary bypass (Hattier et aI., 1995;
Cameron, 1996) and chronic heart failure (Torre-Amione et ai., 1996a; Torre-
Amione et aI., 1996b). Locally produced TNF-a may be an important
contributor to myocardial dysfunction, apoptosis and hypertrophy (Finkel et
aI., 1987; Krown et ai., 1996; Kumar et aI., 1996; Yokoyama et ai., 1997).
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The wide range of activities of TNF-a can be explained by the presence of
TNF receptors in almost all nucleated cell types (Ferrari, 1998). Two distinct
types of receptors for TNF-a have been identified: TNF-RI or TNF-R55 with a
molecular mass of 55-KDa, and TNF-RII or TNF-R75 with a molecular mass
of 77-KDa. The extracellular portion of these two receptors show a significant
sequence homology, but there is a difference between the receptors when
looking at the cytoplasmic domains. This would hint towards the activation of
different intracellular pathways by the two receptors. The ligand-passing
model might explain the different bioactivities of the receptors. This model
suggests that TNF-RII has a much higher affinity and dissociation for TNF
than TNF-RI, binding preferentially TNF at a low ligand concentration. The
ligand is then passed on to the neighbouring TNF-RI, monopolises all TNF
mediated signalling (Vandenabeele et al., 1995; Habib et al., 1996). TNF itself
is a 17-KDa polypeptide. It is expressed as a 26-KDa integral trans-
membrane precursor protein from which the 17-KDa unit is released after
proteolytic cleaving (Vassalli, 1992).
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2.6.1 TNF-aandischaemia-reperfusioninjury
It is thought that locally produced TNF-a can induce post-ischaemic cardiac
dysfunction via two distinct processes: contractile dysfunction and myocyte
apoptosis. Contractile dysfunction can be accomplished either through a nitric
oxide dependent pathway or a nitric oxide independent pathway, the latter is
thought to be a sphingosine dependent pathway (Meldrum, 1998).
Since calcium homeostasis is of such importance to the normal functioning
myocardium, the relationship between TNF-a and calcium have been
investigated. Yokoyama and colleagues (1992) determined that TNF-a
administration led to decrease calcium transient amplitude during systole. It
would seem that TNF-a depresses systolic function by interfering with the
calcium-induced calcium release by the sarcoplasmic reticulum. It has also
been shown that TNF-a disrupts the L-type channel-induced influx (Krown ef
a/., 1995). In addition to this Oral and colleagues (1997) demonstrated that
the early effects of TNF-a on the calcium transient and systolic function are
mediated by sphingosine. The role of NO in this regard would seem to be the
desensitization of the myofilaments to intracellular calcium (Goldhaber ef a/.,
1996). It has been suggested that TNFa-induced sphingosine mediated
disruption of the calcium homeostasis occurs early and that NO mediates the
later desensitisation of the myofilaments to calcium (Figure 2.9) (Gross and
Auchampach, 1992; Kelly and Smith, 1997; Oral ef aI., 1997). It has also
been suggested by some investigators that NO may serve in a protective
capacity during ischaemia and reperfusion (Nakanishi ef a/., 1992; Du Toit ef
a/., 2001). This apparent discrepancy might be due to the different quantities
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of NO produced. It is thought that low levels of NO produced by the calcium-
dependent constitutive form of NOS (eNos) might be protective, whereas the
relatively large amounts of NO produced by calcium-independent, cytokine-
inducible iNOS might be injurious (Nussler and Billiar, 1993; Lyons, 1995).
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Figure 2.9: Myocardial TNF-a production by both cardiac myocytes and
resident cardiac macophages leads to contractile dysfunction. The
immediate phase is NO independent and sphingosine mediated. The late
phase is NO dependent and due to NO-induced desensitisation to
calcium (Adapted from Meldrum, 1998)
NO dependent
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2.6.2 TNF-a and cardiac hypertrophy
When looking at the current literature, it is clear that TNF-a is a mediator of
cardiac pathology exerting its effects, at least in part, through the
inflammatory pathways and via apoptosis. In addition to this it is critical to
realise that TNF-a plays a crucial role in the maintenance and control of
signalling pathways. It is possible that TNF-a is a mediator in cardiac cell
growth and in the remodelling of the cardiac extracellular matrix in response
to biochemical stress (Sack et al., 2000). In this regard Mann (1996) proposed
that short-term expression of TNF-a within the heart might provide an
adaptive response to stress, whereas long-term expression of the cytokine
may be maladaptive by producing cardiac decompensation. The association
of TNF with its homotrimeric cogenate receptor results in the formation of
multimolecular signal transduction complexes, which in turn can activate
several different downstream signalling pathways. Although the coupling of
the adaptor Fas-associated death domain protein (FADO) to TNF-RI is
associated with the activation of apoptotic proteases and programmed cell
death, TNFR-I activation is not usually associated with apoptosis. This is due
to the induction of a complex cytoprotective response that requires TNFR
associated factor 2 (TRAF2), a signal transducer that couples to TNFR-1. This
complex then activates both NFKB-dependentand independent transcriptional
pathways leading to the induction of cytoprotective genes involved in cellular
growth, survival an proliferation (Natoli et al., 1998). These cytoprotective
pathways include hypertrophic growth programmes downstream of protein
kinase C (PKC), stress activated protein kinases (SAPK) and the c-Jun NH?"
terminal kinase (JNK) (Wallach, 1997; Haunstetter and Izumo, 1998; Natoli et
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al., 1998). TNF-a expression and production are upregulated in response to
pressure overload in the adult heart. Kapadia and colleagues (1997) also
demonstrated that simple passive stretch of cat papillary muscle induced the
expression of TNF-a mRNA In addition to this it has also been shown that
physiologically relevant concentrations of TNF-a provoke a hypertrophic
response by increasing the synthesis of structural and contractile proteins in
adult feline cardiocytes (Yokoyama et al., 1997).
With regard to the effects of anabolic steroids on TNFa, Hughes and
colleagues (1995) conducted a study in which they investigated the effect of
anabolic steroids on the immune system. They found that the steroids
nandrolone decanoate and oxmethenelone directly induced the production of
inflammatory cytokines IL-1~ and TNFa from human peripheral blood
lymphocytes. Their data seem to indicate that high doses of anabolic steroids
can have significant effects on immune responses and circulating cytokine
levels (Hughes et al., 1995). Whether AAS have an effect on myocardial
TNFa production is unknown.
It would thus seem that the effects of TNF could be considered either
beneficial or harmful (Figure 2.10), depending on the timing, extent of release
and stability of circulation. In this regard, TNF is either a killer or protector of
its host.
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Figure 2.10: Proposed model for the adaptive and maladaptive roles of
TNFa (Adapted from Sack et al., 2000)
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Chapter 3
Materials and methods
3.1 Animals
Male Long-Evans rats were used throughout the study. Rats were received at
approximately 4 weeks of age weighing between 80 g -100 g. The rats had
free access to food (standard lab chow) and water. They were maintained in
animal quarters at a constant temperature (22°C) and humidity (40%) with a
12-hour artificial day-night cycle.
3.2 Study design
For the purpose of collecting cardiac mechanical function data, rats were
randomly assigned to one of four experimental groups with ten animals
allocated to each group:
• A sedentary placebo group (control)
• A sedentary steroid treated group
• A exercise placebo group
• A exercise steroid treated group
For the collection of tissue for biochemical analyses, a sedentary placebo and
sedentary steroid treated group was used. Here 25 rats were randomly
assigned to each group.
3.2.1 Experimental procedures
The rats were anaesthetized with diethyl ether (8 and M Scientific, Cape
Town). Once anaesthetized, the heart was quickly excised and placed in 4 °C
Krebs-Henseleit solution. The isolated rat heart was then mounted on the
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aortic cannula of the Langendorff perfusion system and perfused within 60
seconds of excision. Excess non-cardiac tissue was removedwhile the hearts
were retrogradely perfused with an oxygenated Krebs Henseleit bicarbonate
buffer. The perfusion solution contained 118,46 mM NaCI; 24,995 mM
NaHC03; 4,748 mM KCI; 1,185 mM KH2P04; 1,19 mM MgS04.7H20 and 1,25
mM CaC12.2H20and 10 mM glucose (Merck Pty.Ltd., Darmstadt, Germany).
The perfusion solution was gassed with 95% 02, 5% C02 for 20 minutes
before and throughout the experiment. The buffer was prepared on the day of
use and filtered through a 0,45 urnMillipore filter.
The initial perfusion period lasted 20 minutes during which time the heart was
allowed to stabilize and blood and enzymes were washed out. A Watson
Marlow 313 peristaltic pump (Watson Marlow Ltd, UK) kept the meniscus of
the buffer in the Langendorff reservoir at a constant level so as to maintain a
perfusion pressure of 100 em H20. The myocardial temperature was
maintained at 37°C throughout the experiment by means of a waterbath
(Grant Instruments, Cambridge, England), that circulated warm water through
the water-jacketed glass reservoirs. A thermistor probe was inserted into the
right coronary sinus to monitor myocardial temperature throughout the
experiment.
3.2.2 Training program
The training program consisted of six swimming sessions per week for 6
weeks. The rats in the exercise groups swam in large concrete baths. The
water was warmed and maintained at a temperature of between 30 to 32°C
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using submersion heaters. Rats swam in groups of ten rats per bath. At the
start of the training programme, the rats swam for a minimum of 5 minutes per
day. The exercising times were systematically increased by 10 minutes a
week until a maximumtraining time of 50 minutes per day was reached.
3.2.3 Steroid administration
Nandralone laurate (Laurabolin 25, Intervet, SA) was diluted 1:10 in peanut
butter oil. The oil was filtered through a 0.22 urn filter to eliminate the
possibility of bacterial contamination. Control rats received pure peanut butter
oil. Rats receiving steroids were injected with 0.375 mg nandrolone laurate
per kg body weight intramuscularly into the hind leg. The initial injection
volume was 100 !-IIper rat. This volume was increased by approximately 50 III
each week in accordance with the increase in body mass in order to maintain
the same weekly nandrolone dosage. In the last week of training each rat was
injected with ±400 III nandrolone laurate. After every weekly injection, each
animal was weighed to calculate percentage body weight gain.
3.3 Experimental design
The protocol consisted of three sequential periods lasting 20 minutes, 20
minutes and 30 minutes respectively, starting with a 10 minute stabilisation
period.
• 0 - 20 minutes: During the pre-ischaemie phase, hearts were perfused
under standard conditions at a perfusion pressure of 100 em H20.
Mechanical function and coronary flows were monitored during this phase.
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• 20 - 40 minutes: During the ischaemie phase hearts were subjected to
global ischaemia. Hearts were submerged in Krebs-Henseleit buffer to
maintain myocardial temperatures of 37°C. A thermistor probe was
inserted into the right coronary sinus to monitor myocardial temperature.
• 40 - 70 minutes: With the onset of reperfusion hearts were perfused with
1% Lignocane Hydrochloride Monohydrate (Peterkaïen, Intramed) for two
minutes in order to reduce the incidence of reperfusion arrhythmias.
Hearts were subsequently perfused with a standard Krebs-Heinsleit buffer
for the remainder of the reperfusion phase.
3.4 Mechanicalfunctionparametersmeasured
3.4.1 Leftventriculardevelopedpressures
The systolic and diastolic pressure was monitored through the insertion of a
compliant balloon into the left ventricle. The balloon consisted of plasticised
PVC ("Glad Wrap") and was inflated with distilled water to a diastolic pressure
of 4 mmHg. Pressure applied on the balloon by ventricular contraction was
monitored with a pressure transducer and data recording system
(Powerlab/200, AD Instruments, Australia). Left ventricular pressure and heart
rate was recorded by means of the software package, Chart for Windows
(Powerlab, AD Instruments, Australia). The balloon's volume was maintained
constant throughout the experiment.
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3.4.2 Coronaryflow
Coronary flow was measured by collecting the hearts effluent for one minute
every 10 minutes. Coronary flow rates varied between 10-15 ml/min. during
normoxic perfusion at a perfusion pressure of 100 cm H20.
3.4.3 Calculationsused
Functional recovery was expressed as the percentage rate pressure product
(RPP) recovery using the following formula:
Where left ventricular developed pressure (LVDP)= Systolic pressure (SP) -
Diastolic pressure (DP)
RPP = Heart rate (HR) x LVDP
% RPPrecovery = (RPPreperfusion!RPPpre-ischaemia)x 100
3.5 Exclusioncriteria
Hearts with coronary flow rates outside the range of 8-20 ml/min, and heart
rates outside of 180-340 beats/min during the stabilisation phase, were
excluded from the study during this stabilisation phase.
3.6 Tissuesamples
Tissue samples were collected for biochemical and molecular biological
analysis. Fifty hearts were freeze clamped with Wollenburger metal tongs,
which were pre-cooled in liquid nitrogen. Samples were collected at 20
minutes perfusion Oust before the onset of ischaemia), after 10 minutes
ischaemia, after 20 minutes into ischaemia and 30 minutes after reperfusion.
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The ventricular tissue was stored in an -BO°C freezer until analyses were
performed.
3.7 Biochemicalanalyses
3.7.1 cGMPdetermination
3.7.1.1 Assaydescription
Cyclic GMP levels were determined using a RIA kit purchased from
Amersham International pic, Amersham, UK.
This assay is based on the competition between unlabeled cGMP and a fixed
quantity of 1251labelled cGMP for a limited number of binding sites on a cGMP
specific antibody. With known amounts of antibody and reactive ligand, the
amount of radioactive ligand bound by the antibody will be inversely
proportional to the concentration of added non-radioactive ligand. The
Amerlex-M secondary antibody reagent contains secondary antibody that is
bound to magnetizable polymer particles. The antibody bound cGMP is
reacted with this secondary antibody reagent and either magnetic separation
or centrifugation of the suspension and decantation of the supernatant results
in the separation of the antibody bound fraction. The amount of labelled
cGMP in the bound fraction can then be calculated by measuring the
radioactivity in the pellet. The concentration of unlabeled cGMP can be
determined by interpolation of a standard curve.
55
Stellenbosch University http://scholar.sun.ac.za
3.7.1.2 Tissue extraction
Approximately 0.1 g of ventricular tissue was fully pulverised in a pre-cooled
metal homogeniser at 4°C. Tissue was extracted using 1.2 ml 6% trichloric
acid (TCA) in Greyward tubes on ice. The extracts were centrifuged at 2000 g
for 15 seconds at 4°C. The supernatant was recovered and the pellet
discarded. The supernatant was then washed 4 times with 5 volumes of
water-saturated diethyl ether, discarding the upper ether layer by aspiration
after each wash. Samples were stored overnight to allow for the remaining
ether to evaporate.
3.7.1.3 Radioimmunoassay
Standards, ranging from 2-128 fmol/tube, and assay buffer were prepared and
all reagents were equilibrated at room temperature. The acetylation reagent
was prepared by mixing 1 volume of acetic anhydrate with 2 volumes of
triethylamine. Then 500 ~I of the assay buffer (0.5 M acetate buffer, pH 5.8
with 0.01% w/v sodium azide) was pipetted into the zero standard acetylation
tube and 500 ~I of each unknown and standard was added to the tubes. The
acetylation reagent (25 ~I) was added to all the acetylation tubes containing
standards and unknowns and vortexed immediately. Duplicate aliquots
(100 ~I) were pipetted from all acetylation tubes into the corresponding assay
tubes and 100 ~I of the antiserum was added to all the assay tubes except to
the total count tube (TC). The assay tubes were vortexed thoroughly, covered
and incubated at room temperature for 1 hour.
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After incubation, 100 IJlof [1251]cGMP was pipetted into all the assay tubes
and the TC was stoppered and set aside for counting. The tubes were
covered and incubated for 15 to 18 hours at 2-8°C.
The Amerlex-M secondary antibody reagent was mixed to ensure a
homogenous suspension and 500 IJlof the secondary antibody was added to
each tube except the TC.
All tubes were then vortexed and incubated for 10 minutes at room
temperature. The antibody bound fraction was separated by means of
centrifugation for 10 minutes at a minimum of 1500 g or greater. After
centrifugation, the tubes were placed into suitable decantation racks and the
supernatant liquid were poured off and discarded. The tubes were kept
inverted and placed on a pad of absorbent tissues and allowed to drain for 5
minutes. On completion of centrifugation separation, the rims of the tubes
were blotted and any adhering droplets of liquid were carefully removed.
Radioactivity present in each tube was determined by counting for at least 60
seconds in a gamma scintillation counter (Cobra™Auto-Gamma, Packard). A
standard curve was obtained and values were expressed as fmol/g ww.
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3.7.2 cAMP determination
3.7.2.1 Assay description
Cyclic AMP levels were determined by Amersham's AMP [H3] radioimmuno
assay kit (Amersham International pic, Amersham, UK).
This assay is based on the competition between unlabelled cAMP and a fixed
quantity of the tritium labelled compound. The amount of labelled protein-
cyclic AMP complexes formed is inversely proportional to the amount of
unlabelled cAMP present in the sample. The protein bound cAMP is
separated from the unbound nucleotide by means of adsorption of the free
nucleotides on to coated charcoal, followed by centrifugation. An aliquot of the
supernatant is then removed for liquid scintillation counting. The concentration
of the unlabelled cAMP in the sample can then be determined from a linear
standard curve.
3.7.2.2 Tissue extraction
Approximately 0.1 g of ventricular tissue was fully pulverised in a pre-cooled
metal homogeniser. Tissue was extracted using 1.2ml 6% perchloric acid
(PCA) in Greyward tubes on ice. Tubes were vortexed, placed on ice for
2 hours with occasional vortexing. The tubes were then centrifuged at 4000
r.p.m for 20 minutes and 1ml of the supernatant was transferred into an
Eppendorf tube containing 5 IJl of universal indicator. The supernatant was
neutralised with two parts 40% saturated KOH -saturated KCL and three
parts 0.2 M Tris-HCL, pH 7.5 (4 DC). These neutral ising volumes were
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recorded. Tubes were then centrifuged for 2 minutes and supernatant
transferred into a new set of Eppendorf tubes.
3.7.2.3 Radioimmuno assay
Standards were prepared by means of serial dilutions. To each of 4 glass
tubes 0.5 ml Tris EDTA buffer was added. Then 0.5 ml of the cyclic AMP
standard was added to the first tube. This was mixed thoroughly and 0.5 ml of
this dilution was added to the next tube and mixed again. This procedure was
repeated successively and a fresh pipette tip was used making each dilution.
The standards ranged from 0.125 to 16 pmol/tube.
Fourteen assay tubes and additional tubes for unknowns, in duplicate, were
placed in a rack and kept on ice. Reagent 1 (0.05 M Tris EDTA buffer, pH7.5)
was pipetted (150 ill) into assay tubes 1 and 2 for the determination of blank
counts per minute of the assay and 50 ill of the Tris/EDTA buffer was pipetted
into assay tubes 3 and 4 for the determination of binding in the absence of
unlabelled cAMP. Starting at the lowest level of standard cAMP, 50 ill of each
dilution were added into each successive pair of assay tubes (tubes 5 to 14)
for the standards ranging from 0.125 to 16 pmol/tube. Then 50 ill of each
unknown, in duplicate, was added to the additional assay tubes. The labelled
cAMP (50 ill) was added to each assay tube and 100 ill of the binding protein
was added to tubes 3 to 14 and to each of the unknowns. All tubes were
vortexed, placed on ice and incubated for two hours in a cold room (2 to BOC).
At least 15 minutes before the end of the incubation time, 20 ml of ice cold
distilled water was added to the charcoal reagent and this was then stirred
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continuously during use. After incubation, 100 1-11the charcoal suspension was
added to all tubes and tubes were vortexed briefly and replaced on ice. Tubes
were then spun down in a refrigerated centrifuge. Without disturbing the
sediment, a 200 1-11sample was removed from each tube and placed in
scintillation vials, containing 5 ml scintillation fluid, for counting (Beckman
Instruments, US). Time elapsed from adding the charcoal suspension to
centrifugation was not less than 1 minute, but not more than 6 minutes. A
standard curve was obtained and values were expressed in pmol/g ww.
3.7.3 P38Determination
3.7.3.1 Preparation of Iysates
Freeze-clamped tissue (approximately 200 mg) was added to sorvall tubes,
each containing 900 1-11of lysis buffer containing (in mM); Tris 20; p-
nitrophenylphosphate 20; EGTA 1; NaF 50; sodium ortovanadate 0.1;
phenyl methyl sulphonyl fluoride (PMSF) 1; dithiotreitol (On) 1; aprotinin 10
I-Ig/ml and leupeptin 10 I-Ig/ml. The tissue and lysis buffer was then
homogenized and spun down in a microfuge to remove the particulate matter.
Protein determination for each sample was conducted using the Bradford
protein determination method (Bradford, 1976). Of each sample, 10 1-11was
taken and 90 1-11of distilled water was added. For the second dilution, 20 1-11of
the previous dilution was taken and 80 1-11of distilled water was added. These
samples were prepared in duplicate.
The lysate protein content was determined by using the Bradford technique.
For the standard curve 5 mg/ml BSA stock solution ([4.76 mg/ml)) was used.
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The dilutions were as follow:
BSA (1-11) H2O Bradford reagent (1-11)
0 100 900
10 x 2 90 900
20 x 2 80 900
40 x 2 60 900
60 x 2 40 900
80 x 2 20 900
The mixtures were vortexed and the absorptions were read at 595 nm within
30 minutes of incubation.
According to the Bradford determination, each sample was diluted in Laemmli
Sample buffer and boiled for 5 minutes.
3.7.3.2 Gel Electrophoreses
After boiling each sample for 5 minutes, 10l-lg of protein was separated on a
12% polyacrylamide gel, using the standard Bio-Rad Mini-PROTEAN II
system (Biorad, Life Science group, US). (Separating gel: 3.35 ml Millipore
H20; 2.5 ml 1.5M Tris-HCI, pH 8.8; 100 1-11 10% SOS; 3 ml Acrylamide; 50 1-11
APS (0.1 g/ml) and 20 1-11 Temed. Stacking gel: 3.05 ml Millipore H20; 1.25 ml
0.5 M Tris-HCI; 50 1-11 10% SOS; 500 1-11 Acrylamide; 50 1-11 10% APS (0.1 gImi);
10 1-11 Temed.) The separated proteins were then transferred to a PVOF
membrane (Immobilin™ -P, Millipore, UK). After staining the membranes with
Ponceau S red (reversible staining), the quality and quantity of the separated
61
Stellenbosch University http://scholar.sun.ac.za
proteins were determined with a laser scanner (UN-SCAN-IT, Silkscience,
US).
Membranes were then washed with TBS Tween to remove Ponceau S red
and non-specific binding sites on the membrane were blocked with 5% fat-
free milk in Tris-buffered saline and 0.1% Tween 20 (TBST) for two hours.
Membranes were then washed again with TBS Tween and blocked with the
appropriate primary antibody (phospho-p38 MAPK [Thr 180ITyr 182]
Antibody, New England Biolabs, UK) for at least five hours. After washing the
membranes with TBS Tween, the immobilized primary antibody conjugated
with a diluted horseradish peroxidase-labelled secondary antibody
(Amersham LIFE SCIENCE, UK) for one hour. The membranes were then
washed thoroughly with TBS Tween and covered with ECl™ detection agents
and quickly exposed to an autoradiography film (Hyperfilm ECl, RPN 2103) to
detect light emission. (ECl ™ Western blotting from Amersham PhArmacia
Biotech, UK). Films were densitometrically analyzed for results.
3.7.4 Myocardial Tumor Necrosis Factor alpha determination
3.7.4.1 Assay Description
An QptEIA™ Rat TNFa ELISA kit (PharmMingen, USA, lot number M065951)
kit was used for the determination of rat tumour necrosis factor-a. The
Cytokine sandwich ELISA is a sensitive enzyme immunoassay that can
specifically detect and quantitate the concentration of soluble cytokine.
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3.7.4.2 Preparation of Iysates
Freeze-clamped hearts were homogenized with 5 volumes of ice-cold lysis
buffer containing in mM/I: imidazole acetate 50, magnesium acetate 10,
potassium hydrogen phosphate 4, EDTA 2, in IJMII: N-acetylcysteine 50 and
sulphur 12.5 (pH 7.6).
Protein determination for each sample was conducted with the Bradford
protein determination method. Of each sample, 10 IJlwere taken and 90 IJl of
distilled water was added. For the second dilution, 20 IJl of the previous
dilution was taken and 80 IJl of distilled water was added. These samples
were prepared in duplicate.
The lysate protein content was determined by using the Bradford technique as
before (see p 60).
3.7.4.3 TNFa ELIZA
The microwells were coated with 100 IJlof anti rat TNFa monolconal capture
antibody diluted in Coating Buffer (0.1 M Carbonate; 8.4 g NaHC03 and 3.56g
Na2C03 made up to 1L, pH 9.5) and incubated overnight at 4°C.
The lyophilized standard was warmed to room temperature and reconstituted
with 1 ml deionized water for a stock standard. The standard was allowed to
equilibrate for a minimum of 15 minutes and vortexed gently before making
dilutions. A 2000 pg/ml standard was prepared from the stock standard and
vortexed. After the standard was mixed, 300 IJl of the assay diluent (animal
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serum in buffered solution with 0.15% ProClin-150 as preservative,
PharMingen, USA) was added to 6 tubes and serial dilutions were performed
by adding 300 !-IIof each standard to the next tube, vortexing in between. The
assay diluent served as the zero standard.
After incubation, wells were aspirated 5 times with 300 !-II or more Wash
Buffer-PBS 0.05% Tween-20 (16 g NaCI, 2.32 g Na2HP04, 0.4 g KH2P04 and
0.4 g KCL made up to 2 I, pH 7.0). After the last wash, the plate was inverted
and blotted on absorbent paper to remove any residual buffer. Plates were
then blocked with 200 !-II/well assay diluent and incubated at room
temperature for 1 hour. After incubation, wells were again aspirated as
described earlier. A 100 !-II of each standard, sample and control were
pipetted into the appropriate wells, the plate was sealed and incubated at
room temperature for 2 hours.
Wells were then aspirated again for a total of 5 washes. After the plates were
washed, 100 !-IIof the detection antibody (Biotinylated anti-rat TNFa), diluted
in assay diluent (1 :250), was pipetted into each well and the plate was sealed
and incubated for 1 hour at room temperature.
After incubation, wells were washed and aspirated for 5 times. After
aspiration, a 100 !-II of enzyme reagent (Avidin-horseradish peroxidase
conjugate) diluted in assay diluent (1 :250), was added to each well, the plate
sealed and incubated at room temperature for 1 hour.
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Wells were again aspirated, but this time for a total of 7 washes and wells
were soaked in wash buffer for 30 seconds to 1 minute with each wash. A
100 IJl TMB substrate solution (3,3', 5,5' tetramethylbenzidine and hydrogen
peroxide in organic solvent, PharMinge, USA) was added to each well and the
plate was incubated in the dark at room temperature for 30 minutes.
After the incubation 50 IJl of the stop solution (1 M H3P04 or 2 N H2S04) was
added to each well to terminate the reaction. The absorbance was read at
450 nm within 30 minutes of stopping the reaction. A standard curve ranging
between 31.3 pg/ml to a 1000 pg/ml was obtained. Values obtained were
presented as pg/gram ww.
3.8 Statiscal Methods
The Unpaired Students t-test was used to do statistical analysis of the
biochemical and biological data. The ANOVA with Bonferroni corrections for
multiple comparisons was used to determine the statistical significance of all
other data. Data are presented as means± standard error of the mean (SEM).
A P value equal to or smaller than 0.05 was considered as significant. The
statistical program GPIS was used to perform all statistical analyses.
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Chapter4
Results
4.1 Biometric data
4.1.1 Rat weights before and after treatment
Comparisons of rat body weights before treatment did not show any
significant differences between the four groups. Similarly no differences were
found in rat weights after treatment.
Table 4.1: Rat weights before and after treatment in the sedentary
(control) placebo group, the sedentary steroid treated group, the
exercise placebo group and the exercise steroid treated group
Sed~lac Sedster
Before (g) After (g) Before (g) After (g)
n = 10 n=8 n = 10 n=8
89.32 ± 4.79 310.33 ± 10.88 86.65 ± 4.85 298.35 ± 8.66
Exerplae Exerster
Before (g) After (g) Before (g) After (g)
n = 10 N = 10 n =10 n=8
82.57 ± 4.56 300.35 ± 13.20 88.27 ±4.45 294.12 ± 16.33
All values are expressed as mean ± SEM.
Abbreviations: Sedplac- sedentary placebo group; sedster- sedentary
steroid group; exerplac- exercise placebo group; exerster- exercise steroid
group
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4.1.2 Heart weight to body weight ratio
The heart weight to body weight ratio was different when comparing the
sedentary steroid (4.0 ± 0.19 mg) and exercise steroid groups (4.68 ±
0.13 mg) (p < 0.05). The heart weight to body weight ratio was similar in all
the other groups.
sedplac exerplacsedster exerster
Groups
Figure 4.1: Heart weight to body weight ratio for the sedentary placebo
group (control), the sedentary steroid treated group, the
exercise placebo group and the exercise steroid treated
group.
n= 8-14
All values are expressed as mean ± SEM.
Abbreviations: sedplac- sedentary placebo group; sedster- sedentary steroid
group; exerplac- exercise placebo group; exerster- exercise steroid group
* p-e0.05 sedster vs. exerster
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4.1.3 Plasma cholesterol, HOL cholesterol and triglyceride levels
A difference was found when the plasma cholesterol levels of the sedentary
placebo (2.04 ± 0.09 mmol/I) and sedentary steroid groups (1.81 ±
0.05 mmol/I) were compared (p < 0.05). No differences were found in the HOL
cholesterol and TAG levels between the sedentary placebo and sedentary
steroid groups.
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Figure 4.2: Plasma cholesterol, HOL cholesterol and triglyceride levels
in the sedentary (control) placebo group and the sedentary
steroid treated group.
n = 9 for each respective group
All values are expressed as mean ± SEM.
Abbreviations: sedplac- sedentary placebo group; sedster - sedentary
steroid group; Pl.chol - plasma cholesterol; HOL chol - high-density lipoprotein
cholesterol; Pl.TAG - plasma triglyceride
* p < 0.05 for sedplac vs. sedster
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4.1.4 Haemodynamicfunction
There were no significant statistical differences in coronary flows when
comparing the four groups.
Pre-ischaemieheart rate and left ventricular developed
pressures
There were statistical differences in heart rate when comparing sedentary
placebo group (282 ± 9.61 beats/min) and the exercise placebo group (241 ±
4.1.4.1
12.10 beats/min) (p < 0.05) at 30 minutes pre-ischaemia. All of other groups
had similar heart rates.
There were no differences between left ventricular developed pressure when
comparing the four groups.
4.1.4.2 Reperfusion heart rate and left ventricular developed
pressure
There were no statistical differences in heart rate during reperfusion when
comparing the four groups.
A difference was found for left ventricular developed pressure when
comparing the sedentary placebo (62.75 ± 4.27 mmHg) and exercise placebo
(89.57 ± 9.28 mmHg) groups at 20 minutes reperfusion. (p < 0.05). At 20
minutes reperfusion there was also a difference between the exercise placebo
group (89.57 ± 9.28 mmHg) and the exercise steroid group (57.67 ± 9.36
mmHg) (p < 0.05). This difference persisted at 30 minutes of reperfusion
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between the exercise placebo group (91.29 ± 8.94 mmHg) and the exercise
steroid treated group (58.89 ± 5.00 mmHg) (p< 0.05).
Table4.2: CF, HR, and LVDP for the sedentary (control) placebo
group, the sedentary steroid treated group, the exercise
placebo group and the exercise steroid treated group
Grou~s Pre-ischaemia Reperfusion
Functional
parameters 30 minutes 20 minutes 30 minutes
Sedplac CF (ml/min) 16.50 ± 0.53 15.68 ± 0.78 14.78±1.12
n=8 HR (beats/min) 282 ± 9.61 255 ± 16.68 259 ± 19.96
LVDP(mmHg) 113.75 ± 6.05 62.75 ± 4.27 70.37 ± 5.21
Sedster CF (ml/min) 14.16 ± 0.66 12.93 ± 0.78 11.64 ± 0.55
n=9 HR (beats/min) 278 ± 14.10 240 ± 25.30 216 ± 17.56
LVDP(mmHg) 111.11 ± 4.25 52.22 ± 8.78 55.89 ± 6.43
Exerplac CF (ml/min) 17.88 ± 0.62 16.83 ± 0.73 16.63 ± 0.57
n = 14 HR (beats/min) 241 ± 12.10# 239 ± 16.29 233 ± 19.51
LVDP(mmHg) 128.79 ± 5.87 89.57 ± 9.28# 91.29 ± 8.94
Exerster CF (ml/min) 14.16 ± 0.64 13.40 ± 1.22 12.24 ± 1.37
n=9 HR (beats/min) 247 ± 21.20 215 ± 26.32 220 ± 18.62
LVDP(mmHg) 115.11 ± 4.12 57.67 ± 9.36* 58.89 ± 5.00*
All values are expressed as mean ± SEM.
Exerplac - exercise placebo group; exerster - exercise steroid group; HR-
heart rate; CF - coronary flow; LVDP - left ventricular developed pressure
* p < 0.05 for exerplac vs. exerster
# P < 0.05 for sedplac vs. exerplac
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4.1.5 Left ventricular developed pressure before and after
ischaemia
150-C>
J:
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Figure 4.3: Left ventricular developed pressure before and after
ischaemia for the sedentary placebo group (control) ,the
sedentary steroid treated group, the exercise placebo group
and the exercise steroid treated group.
n = 8-14
All values are expressed as mean ± SEM.
Abbreviations: sedplac - sedentary placebo group; sedster - sedenary
steroid group; exerplac - exercise placebo group; exerster - exercise steroid
group; LVDP - left ventricular developed pressure
* p < 0.05 for exerplac vs. exerster
# P < 0.05 for sedplac vs. exerplac
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4.1.7 Ratepressureproductbeforeandafter ischaemia
Because heart rates were different in certain groups before ischaemia, rate
pressure product values were also determined to quantify mechanical function
of the hearts.
Pre-ischaemie rate pressure products were different at 20 minutes perfusion
(34582.00 ± 1778.13 mmHg/min vs. 28868.67 ± 2446.02 mmHg/min) when
comparing the exercise placebo and exercise steroid groups and this
difference persisted at 30 minutes perfusion (34582.00 ± 1778.13 mmHg/min
vs. 28868.67 ± 2446.02 mmHg/min), This difference persisted at (22196.29 ±
2904.93mmHg/min vs. 10128.89 ± 1447.00 mmHg/min), 20 (21753.36 ±
2917.17 mmHg/min vs. 11275.33 ± 1941.19 mmHg/min) and 30 minutes
reperfusion (21892.21 ± 2912.14 mmHg/min vs. 12838.67 ± 1536.50
mmHg/min) (p < 0.05). When comparing the sedentary placebo and sedentary
steroid treated groups, there was a difference at 10 minutes (14811.38 ±
1825.61 mmHg vs. 7950 ± 1441.66 mmHg/min) (p < 0.05), 20 minutes
(16169.63 ± 1772.88 vs. 11243.67 ± 1516.49) (p < 0.05) and 30 minutes
(18276.38 ± 2026.10 mmHg/min vs. 12018.67 ± 1725.27 mmHg/min) (p <
0.05) reperfusion.
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PERFUSION REPERFUSION
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Figure 4.4: Rate pressure product before and after ischaemia for the
sedentary (control) placebo group, the sedentary steroid
treated group, the exercise placebo group and the exercise
steroid treated group.
n = 8 - 14
All values are expressed as mean ± SEM.
Abbreviations: sedplac - sedentary placebo group; sedster - sedentary
steroid group; exerplac - exercise placebo group; exerster - exercise steroid
group; RPP - rate pressure product
* p < 0.05 for exerplac vs. exerster
# P < 0.05 for sedplac vs. sedster
** p< 0.05 for sedplac vs. sedster
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4.1.8 Percentageratepressureproductrecovery
When comparing the rate pressure product recoveries of the sedentary
placebo and sedentary steroid treated groups, there was a difference at 10,
20 and 30 minutes reperfusion (46.0 ± 5.37% vs. 26.09 ± 4.56%, 50.90 ±
5.04% vs. 36.93 ± 4.79% and 58.01 ± 6.47% vs. 39.89 ± 5.94%) (p < 0.05). At
10 minutes (61.12 ± 6.39% vs. 37.32 ± 5.96%) and at 20 minutes (59.04 ±
6.56% vs. 39.87 ± 6.22%) of reperfusion differences was found between the
exercise placebo and exercise steroid groups (p < 0.05).
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Figure 4.5: Percentage rate pressure product recovery for the sedentary
placebo group (control), the sedentary steroid treated
group, the exercise placebo group and the exercise steroid
treated group.
n = 8-14
All values are expressed as mean ± SEM
Abbreviations: sedplac - sedentary placebo group; sedster - sedentary
steroid group; exerplac - exercise placebo group; exerster - exercise steroid
group; RPP - rate pressure product.
* p < 0.05 for sedplac.vs. sedster
# P < 0.05 for exerplac vs. exerster
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4.2. Biochemical results
4.2.1 Tissue cGMP values
When comparing the sedentary placebo group (control) with the sedentary
steroid group, a difference was found between the two groups at 30 minutes
pre-ischaemia (7.381 ± 0.280 pmol/g vs. 9.159 ± 0.815 pmol/g), 10 minutes
ischaemia (9.977 ± 2.476 pmol/g vs. 20.814 ± 3.457 pmol/g) and 20 minutes
of ischaemia (20.547 ± 3.034 pmol/g vs. 11.633 ± 2.807 pmol/g) (p < 0.05).
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Figure 4.6: Tissue cGMP levels in the sedentary placebo group
(control) and the sedentary steroid treated group.
n = 5-7
All values are expressed as the mean ± SEM.
Abbreviations: sedplac - sedentary placebo group; exerster - exercise
steroid treated group
* = p < 0.05 for sedplac vs. sedster
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.2.2 Tissue cAMP levels
cAMP levels were elevated in the non-ischaemie steroid treated hearts
(406.04 ± 18.41 pmollg) when compared to the placebo treated rats(235.6 ±
43.26 pmollg) (p < 0.05). There was no difference in cAMP levels during
ischaemia and reperfusion in the two groups.
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Figure 4.7: Tissue cAMP levels in the sedentary placebo group
(control) and the sedentary steroid treated group.
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Abbreviations: sedplac - sedentary placebo group; sedster - sedentary
perfusion time
n = 5 - 6
All values are expressed as the mean ± SEM.
steroid group
* p < 0.05 for sedplac vs. sedster
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4.2.3 P38Mitogenactivated protein kinase activity
There was no difference between the sedentary placebo and sedentary
steroid treated group when comparing the degree of p38 MAPK activation.
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Figure4.8: Degreeof p38MAPKactivation for sedentary placebo group
(control) and steroid treated group.
n = 4 for the respective groups
All values are expressed as mean ± SEM.
Abbreviations: sedplac - sedentary placebo group; sedster- sedentary
steroid group
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4.2.4 Myocardial TNFa values
There was a difference in myocardial TNFa levels at 30 minutes perfusion
between the sedentary placebo group (190.00 ± 15.75 pg/g) and the
sedentary steroid group (267.75 ± 44.25pg/g) (p < 0.05). No statistical
difference between the two groups was observed during the ischaemie period.
However, at 30 minutes reperfusion the steroid treated group showed higher
levels of TNFa (511.13 ± 13 pg/g vs. 287.63 ± 59.95 pg/g).
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Figure 4.9: Myocardial TNFa levels for the sedentary placebo group
(control) and the sedentary steroid treated group.
n = 3 - 6
All values are expressed as the mean ± SEM
Abbreviations: sedplac - sedentary placebo group; sedster - sedentary
steroid treated group
* = p < 0.05 for sedplac vs. sedster
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Chapter 5
Discussion
It was investigated whether androgenic anabolic steroid administration has a
detrimental effect on the hearts of sedentary and exercised rats. The purpose
of this study was to determine whether there is a link between anabolic steroid
induced cardiac hypertrophy and the severity of myocardial
ischaemia/reperfusion injury and to possibly gain some insight into the
mechanisms for the detrimental effects of the steroids on the heart.
The biometric data indicated that there were no significant differences in rat
weights among the four groups before treatment. Similarly, no differences
were found after treatment and/or exercise training. Heart weight to body
weigh ratio was used as an index of cardiac hypertrophy. In this regard the
exercising steroid treated animals exhibited greater cardiac hypertrophy when
compared to their sedentary steroid treated counterparts. Plasma cholesterol,
HDL cholesterol and TAG were measured and a significant difference in
plasma cholesterol was found when comparing the sedentary steroid treated
group with the sedentary control group, the latter having higher cholesterol
levels.
Haemodynamic parameters measured included heart rate, coronary flow rate
and left ventricular developed pressure. As far as coronary flow rate is
concerned, no statistical differences were observed among the four groups.
The pre-ischaemic heart rate of the exercise-trained animals was significantly
lower than that of their sedentary counterparts. There was no statistical
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difference in left ventricular developed pressure for the four groups when
measured before ischaemia. Left ventricular developed pressure differed
significantly during reperfusion for the exercise placebo group compared with
sedentary placebo group (10 minutes reperfusion) and for the exercise steroid
treated group compared with the exercise placebo group (20 and 30 minutes
of reperfusion).
As an index of mechanical function of the hearts, rate pressure product was
used, while rate pressure product recovery was used as an index of post-
ischaemic recovery.
Pre-ischaemic function of the exercising placebo treated group was
significantly better when compared to the exercising steroid treated animals
and the sedentary control group. Post-ischaemic function of the exercising
placebo treated group consistently showed a better function when compared
to the exercise steroid treated animals. Another consistent statistical
difference was seen between the sedentary control group and the sedentary
steroid treated group with the latter showing the poorer functional recovery of
the two groups. At the beginning of reperfusion, there was a difference
between the sedentary steroid treated and exercise steroid treated animals.
The exercise-trained group displayed the better RPP of the two. Lastly,
statistical differences were also found between the sedentary placebo and
exercise placebo (control) groups during this period. The trained animals
again displayed better reperfusion function recovery than their sedentary
counterparts.
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For the purpose of biochemical investigation, myocardial cGMP, cAMP, TNFa
and p38 levels were measured in the sedentary placebo treated and in the
sedentary steroid treated animals. The control animals had significant higher
cGMP levels during the pre-ischaemic phase and early during the ischaemic
phase, displaying no statistical differences during the reperfusion phase.
Myocardial cAMP levels were statistically greater in the steroid treated
animals during the pre-ischaemic phase, which may indicate that steroid
treatment increased non-ischaemic myocardial cAMP levels. The normaxic,
non-ischaemic hearts of the steroid treated rats had significantly higher TNFa
levels than their non-treated counterparts. At 30 minutes reperfusion, the
steroid treated animals again displayed signifiantly higher myocardial TNFa
levels. No statistical differences were found between the two groups when
measuring p38 activity before, during and after ischaemia.
5.1 Rat weights before and after treatment
There were no significant differences between the weights of the four
experimental groups prior to treatment. Any differences in the animals' end
weight after treatment and/or exercise would be ascribed to the treatment
administered. The study did not yield any differences in body weights between
the four groups. In contrast to this, Liang and colleagues (1992) found larger
weight gains in steroid treated and exercise steroid treated groups compared
to control and exercise groups. These conflicting results are probably due to a
difference in experimental protocol. Liang and colleagues (1992) injected rats
with a starting dose of 1.5 nandrolone decanoate mg/kg body weight for
between 42 to 63 days ending with a dosage of 3.0 mg nadrolone decanoate
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per kg body weight. This is a much higher dosage than that used in this study
(0.375 mg/kg body weight) and the duration of treatment was also longer in
the study performed by Liang and colleagues (1992).
In agreement with our results, Philips and colleagues (2000) found no
evidence of a generalised anabolic effect of nandrolone in their unexercised
animals. Kinson and colleagues (1991) found that neither castration nor
treatment with AAS produced any significant change in body weight.
5.2 Heart weight to body weight ratio
Cardiac hypertrophy is a fundamental process of adaptation to an increased
workload due to haemodynamic overload (Cooper 1987; Mondry and
Swynghedauw, 1995). This adaptation would appear to be beneficial at first
by increasing the number of contractile units, thus compensating for the
increased workload and hence reducing left ventricular wall stress. This
beneficial adaptation is limited however, because at a certain point the
adaptational value is replaced by detrimental cardiac hypertrophy, even
leading to heart failure (Ruwhof and Van der Laarse, 2000). Several stimuli
exist to induce cardiac hypertrophy of which the most important seems to be
mechanical stress.
The use of androgenic anabolic steroids usually goes hand in hand with
exercise training. Exercise induced cardiac hypertrophy has been studied
extensively and studies have been done to investigate the effects of the
combination of exercise and anabolic steroid treatment. Little conclusive data
is however available with regard to the relationship between AAS and cardiac
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hypertrophy in untrained subjects. Findings in these studies have been
numerous and diverse.
Exercise training results in physiological left ventricular hypertrophy
associated with increases in left ventricular end diastolic internal dimensions
(de Maria et aI., 1978). It has been shown that high-dose androgenic steroid
administration produces a leftward shift in the left ventricular end diastolic
pressure internal dimension relationships (Trifunovic et aI., 1995; Trifunovic et
aI., 1998). In these two studies it has also been reported that high-dose
androgenic steroid administration resulted in a reduction in left ventricular
weight in sedentary animals. Takala and colleagues (1991) have reported that
simultaneous anabolic steroid administration and exercise training prevents
cardiac hypertrophy observed after endurance training in dogs.
In the present study the heart weight to body weight ratios of the four groups
were compared as an indirect index of cardiac hypertrophy. Although the
exercise group showed signs of possible cardiac hypertrophy, the exercise
steroid treated group had distinct cardiac hypertrophy. A significant difference
in heart weight to body weight was found between the sedentary steroid
treated group and the exercised steroid treated animals, with the latter having
larger hearts relative to their body weights.
It is a well known fact that exercise training leads to cardiac hypertrophy. The
greater hypertrophy displayed in the steroid treated rat hearts would suggest
a cumulative effect of exercise and androgenic anabolic steroids on cardiac
hypertrophy. Indeed, several studies have verified that the use of anabolic
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steroids lead to an increase in peripheral vascular resistance and cardiac
hypertrophy when combined with exercise (Appel et aI., 1983; Karhunen et
aI., 1988; Dickerman et aI., 1997). Cardiac hypertrophy was not observed with
sedentary steroid treated animals. The mechanism by which AAS causes
hypertrophy of the cardiac myocytes is still unclear. Androgen receptors are
present in cardiac myocytes, which may allow androgens to induce
myocardial hypertrophy by direct receptor specific mechanisms.
5.3 Lipidprofiles
The relationship between androgenic anabolic steroid use and changes in
lipid profiles has been investigated in both non-primate and primate models
and is currently controversial. In many primate models, the use of anabolic
steroids not only leads to an increase in LDL cholesterol, but also to a
concomitant decrease in HDL cholesterol (peltonen et aI., 1981; Stubbe et aI.,
1983; Lenders et aI., 1988;Weyrich et aI., 1991).
Present results did not show any significant changes in the HDL cholesterol or
triglyceride levels. It did however show a statistical difference in the plasma
total cholesterol with the controls displaying the higher levels. In a study done
by Glazer and Suchman (1994) in which they injected 21 men and 3 women
with nandrolone decanoate intramuscularly once a week for six weeks. No
significant change was noted in high-density lipoprotein (HDL) cholesterol,
low-density lipoprotein (LDL) cholesterol, total cholesterol, triglycerides, the
total cholesterol to HDL-C ratio, or the LDL-C/HDL-C ratio from nandrolone
treatment. In a recent study done by Wolffenbuttel and colleagues (1999) they
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injected 12 male weight lifters with 200 mg nandrolone decanoate per week
(intramuscularly) for 8 weeks. Their results suggested that, perhaps unlike
other anabolic steroids, nandrolone decanoate, even in high doses, does not
have a detrimental effect on the subjects' lipid profiles. These studies concur
with our findings, perhaps due to the fact that we also used a nandrolone
derivative.
5.4 Heamodynamicfunction
5.4.1 Heartrate
An important difference was seen when comparing the pre-ischaemie heart
rate of the sedentary placebo group and the exercise placebo group. The
exercise group exhibited the lower heart rate of the two, indicating adaptation
to exercise in the trained animals. This adaptation is usually referred to as
training-induced bradycardia where the resting heart rate of the trained
individual is lowered. In a study done as early as 1977, Sigvadsson and
colleagues used Sprague-Dawley rats, normal and chemically
sympathectomized with 6-hydroxy-dopamine and then trained by treadmill
running. The normal rats showed a reduction in exercising heart rate after the
training period. Compared to a sedentary control group, the
sympathectomized rats showed no statistical difference in intrinsic heart rate
after pithing and denervation and no increase in heart weight. These findings
suggest that endurance training induces enhanced vagal activity and
attenuated sympathetic tone, which may in part contribute to the resting
bradycardia and an increase in the spontaneous bradycardia in athletes
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(Shin et ai., 1995). How the isolated heart is affected by this mechanism is not
clear and remains to be elucidated.
5.4.2 Pre-ischaemiecardiacfunction
The exercise-trained animals displayed the highest pre-ischaemie (as well as
post-ischaemie) rate pressure product, i.e. function, throughout the
experiment compared to the other three groups. The cardiovascular benefits
of exercise are well established and have been studied extensively (Morris et
ai., 1980; Siscovick et ai., 1984). It has been suggested that exercise training
improves cardiac function without evidence of cardiac apoptosis and produces
a pattern of cardiac gene expression distinct from the pathological cardiac
adaptation to exercise (Jin et ai., 2000). When comparing the trained animals
to those receiving AAS, it would appear that the anabolic steroids reduced the
training induced beneficial effects on cardiac function. These negative
changes may be related to AAS induced changes in basal cyclic nucleotide
levels in the heart (see later).
5.4.3 Post-ischaemiefunction
The role of ischaemia and ischaemia/reperfusion injury in the heart has been
studied extensively. However, no literature could be found on the effects of
AAS on function of the post-ischaemie heart. Acute ischaemia induces a wide
variety of detrimental effects in the heart, which is usually exacerbated during
reperfusion (Boyle et ai., 1997). In the present study reperfusion function, i.e.
recovery of heart function after an episode of global ischaemia, was used in
order to determine the severity of the ischaemia/reperfusion injury. In this
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regard we wanted to determine whether hypertrophy and/or anabolic steroids
would increase or decrease myocardial susceptibility to ischaemiclreperfusion
injury.
The detrimental changes ischaemia induced in the myocardium are brought
about by complex mechanisms. These include the depletion of energy stores
(Jennings et al., 1983; Maxwell and Lip; 1997), cellular leakage with
accompanied disruption of cellular homeostasis (Maxwell and Lip, 1997) and
the accumulation of metabolic waste products such as lipid metabolites (Carr
et al., 1993). Although data on anabolic steroids and the direct role they play
in ischaemia/repefusion injury are scarce, there is a substantial amount of
evidence implicating AAS in myocardial infarction and related heart diseases
(Kennedy and Lawrence, 1993; Huie, 1994;Appelby et al., 1994).
To our knowledge the present study is the first to investigate the effects of
AAS on myocardial susceptibility to ischaemic/reperfusion injury. It is
generally thought that AAS users/abusers are at greater risk of
atherosclerosis- thought to be secondary to increased concentrations of LDL-
C and decreased concentration of HDL-C (Hurley et al., 1984).
To study the possible detrimental effects of androgenic anabolic steroids on
the heart and its resistance to ischaemia/reperfusion injury, a sedentary group
and a sedentary steroid treated group was compared. Although there was no
statistical difference in function between the two groups during the pre-
ischaemic phase, there was a definite difference in function during the
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reperfusion phase, with the untreated group of hearts consistently recovering
better than the steroid treated group. This can be seen in both the rate
pressure product values and the percentage recovery data. From the data
gathered in the present study, it can be concluded that the lowering of cardiac
performance, before and after an ischaemie incident, can also be attributed to
other factors besides the lipid profiles, since we did not find the lipid profiles to
be altered negatively in the treated animals.
This would suggest that AAS make the heart more prone to
ischaemia/reperfusion injury by mechanisms independent of its effects on the
lipid profiles. Possible explanations for this, disregarding an atherogenic
model due to detrimental lipid profiles, include AAS-induced thrombosis,
inhibited vascular smooth muscle relaxation and perhaps direct injury of the
myocardial cells (Melchert and Welder, 1995).
5.5 Effectof AASon selectedbiochemicalparameters
5.5.1 cyclic GMP
Activation of the NO-cGMP pathway is thought to protect the heart against
ischaemia/reperfusion injury. It has also been proposed that estrogen, known
for its cardiovascular benefits, might protect the heart through activation of
this pathway (Wellman et al., 1996). Since one of the possible mechanisms of
AAS-induced cardiac injury is mediated through the inhibition of guanylate
cyclase, leading to the lowering of cGMP levels (Melchert and Welder, 1995),
Cyclic GMP levels were measured in the hearts of the two sedentary groups
of animals. Previously it was seen that chronic administration of nandrolone to
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rabbits resulted in decreased thoracic aorta relaxation possibly by inhibiting
guanylyl cyclase (Ferrer et aI., 1994). In the present study the untreated
animals displayed lower levels of myocardial cGMP under normoxic
conditions when compared with steroid treated hearts. This may indicate that
myocardial guanylyl cyclase is stimulated in the steroid treated hearts. During
ischaemia there were no statistical differences in myocardial cGMP levels.
What cannot be disregarded are the higher cGMP levels with the onset of the
experiments in the treated animals. It would be reasonable to suggest that
treatment with steroids possibly stimulated guanylyl cyclase activity under
normoxic conditions. What we could not establish from this work is whether
the beneficiary effects of steroid induced elevations in myocardial cGMP are
not being overshadowed by the effects of AAS on cAMP levels.
5.5.2 Cyclic AMP
As mentioned earlier, evidence has accumulated over the years implicating
cytosolic Ca2+ overload in myocardial ischaemic/reperfusion injury (Marban et
ai., 1989; Du Toit et aI., 1992). Since factors leading to increased cytosolic
calcium include adrenergic stimulation leading to cAMP activation, it was
investigated whether androgenic anabolic steroids had an effect on
myocardial cAMP levels. To our knowledge, this is the first attempt to do so.
Indeed, a significant difference was found in pre-ischaemic myocardial values
with the steroid treated animals displaying higher myocardial cAMP levels.
These elevated levels of cAMP prior to ischaemia could make AAS treated
hearts more susceptible to ischaemiclreperfusion injury compared to their
untreated counterparts. One would expect these hearts to have elevated
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cytosolic Ca2+ levels at the onset of ischaemia which would be expected to
worsen ischaemie Ca2+ overload and, as a consequence, ischaemicl
reperfusion injury.
5.5.3 P38Mitogenactivatedproteinkinase
The mitogen activated protein kinase, p38, is thought to playa dual role with
regard to cardiovascular injury. On the one hand, it can engage in a protective
role, activating small heat shock proteins (Rouse et ai., 1994), protecting the
heart against ischaemia/reperfusion injury. On the other hand, several studies
have shown it to be deleterious, exacerbating ischaemia/reperfusion injury
(Ma et ai., 1999; Saurin et a/1999). To the best of our knowledge we are the
first to investigate whether there is a correlation between anabolic steroid
treatment and myocardial p38 activity. Although no significant statistical
differences were found between the steroid treated and control groups, a
tendency seems to exist for elevated levels of p38 in the steroid treated
animals, particularly during ischaemia. A clearer indication of the effects of
AAS on P38 activity may be obtained if the number of hearts for these
determinations were to be increased.
5.5.4 MyocardialTNFo
Tumour necrosis factor alpha is a mediator of several processes in the heart.
Several conditions can stimulate TNFa production, including ischaemia and
reperfusion (Gurevitch et ai., 1996). TNFa produced locally in the heart may
be important in the induction of myocardial dysfunction, apoptosis and
hypertrophy (Finkel et ai., 1987; Krown et ai., 1996; Kumar et ai., 1996;
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Yokoyama et al., 1997). On the other hand, it has been suggested that low
acute or subacute exposure of the heart to TNFa may be adaptive, while
chronic exposure to low or increasing concentration of TNFa is maladaptive
and leads to heart failure (Sack et al., 2000).
There are indications that AAS may stimulate TNFa formation in lymphocytes.
We propose that AAS may also stimulate myocardial TNFa synthesis. We, to
our knowledge, are the first to investigate whether TNFa may be linked to the
exacerbation of ischaemic/reperfusion injury in AAS treated hearts. Pre-
ischaemic myocardial TNFa levels were higher in the AAS treated animals
than their untreated controls. This would suggest that AAS led to elevated
levels of myocardial TNFa in the animals during treatment. These elevated
TNFa levels may have contributed to both the poorer mechanical function of
the normoxic heart and to the exacerbation of ischaemic/reperfusion injury.
The elevated TNFa levels during the 30 minute reperfusion phase may
contribute to suppressing myocardial function as it is known that elevated
myocardial TNFa can suppress mechanical function through sphingomyelin
and NOS-cGMP pathways.
Again, it might be helpful to increase the group numbers. Another possible
suggestion would be to collect blood while treating the animals to also
determine circulating serum TNFa levels.
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Chapter 6
Conclusions
Animals subjected to androgenic anabolic steroid treatment together with an
exercise training program developed myocardial hypertrophy. It was also
found that AAS reduced the beneficial myocardial effects of exercise training
as seen in the lowered heart function of the steroid treated group. There was
also a reduction in reperfusion function in the steroid treated animals
indicating that AAS may make the heart more susceptible to
ischaemia/reperfusion injury.
It is also possible that the detrimental pre-ischaemie cyclic nucleotide ratio,
i.e. extremely high cAMP levels and marginally elevated cGMP levels, in
steroid treated sedentary animals could make these hearts more prone to
ischaemia/reperfusion injury. The higher pre-ischaemie and reperfusion levels
of TNFa could also contribute to this.
Future investigation and study reservations
The collection of blood samples during the exercise-training program and
steroid treatment would confirm whether AAS increases circulating TNFa
levels during the treatment program. There was an indication that AAS
treatment affected the MAPK pathway, with special reference to P38. To
establish whether this is the case, greater sample numbers must be obtained.
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Lastly, we found literature indicating that nandrolone laurate had little effect on
lipid profiles and body weight gain. It might be advisable to use an AAS also
affecting these parameters. With regard to the training program, we advise
that tail weights be added to increase resistance training during swimming.
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